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ABSTRACT

Recombinant, thermostable alpha-glucosidases from
archaeal micro-organisms and isolated DNA encoding for
Such alpha-glucosidases are provided. The isolated DNA is
obtained by use of DNA or antibody probes prepared from
the DNA encoding S. SulfataricuS alpha-glucosidase. Also
provided are methods for producing recombinant archaeal
thermostable alpha-glucosidase and transformants incorpo
rating thermoStable alpha-glucosidase. Autoprocessing of
plant tissue through the use of transgenic thermostable
glycosyl hydrolases is described.
9 Claims, 18 Drawing Sheets
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1
HYPERTHERMOPHILIC ALPHA
GLUCOSIDASE GENE AND ITS USE

This application is related to U.S. provisional patent
application Ser. No. 60/096,860, filed Aug. 18, 1998, incor
porated herein by reference.
BACKGROUND OF THE INVENTION

The present invention relates to a novel nucleic acid
coding for a thermostable glycosyl hydrolase, alpha
glucosidase, from the archaeon SulfolobuS SolfataricuS and
a novel enzyme coded by its gene, malA. It also relates to
bacteria and plants transformed with hyperthermophilic
alpha-glucosidase and a method for preparing the recombi
nant alpha-glucosidase by use of the same. The present
invention further relates to a method of using the transgenic
thermostable glycosyl hydrolases for the bioprocessing of
plant carbohydrates.
The publications and other materials used herein to illu
minate the background of the invention or provide additional
details respecting the practice, are incorporated by reference,
and for convenience are, in part, respectively grouped in the
appended List of References.
A variety of industries, Such as food and chemical,
employ hydrolases for the production of glucose, Sucrose
and other Sugars. High value is placed on thermoStability
and thermoactivity of enzymes for use in the bioprocessing
of Starch into maltodextrins, glucose, fructose and various
other SugarS.
One hydrolase, alpha-glucosidase, is defined by the Inter
national Union of Biochemistry as an enzyme which hydro
lyzes glucose oligomers to glucose. Alpha-glucosidase and
other glycosidase genes from non-thermophilic eukaryotic
and eubacterial organisms have been cloned and character

15

25

SUMMARY OF THE INVENTION

35

ized (Hermans, et al., 1991). In addition, the major,

endogenous, Soluble alpha-glucosidase from SulfolobuS Sol
fataricuS has been purified and characterized. Although it
has not, to date, been cloned, the native enzyme hydrolyzes
Sucrose and liberates glucose from maltose. It has a tem
perature optimum in excess of 100° C., with a prolonged half
life at elevated temperatures, and is resistant to proteolysis
and denaturants including chaotropes, detergents and ali

40

phatic alcohols (Rolfsmeier and Blum, 1995). Another

hydrolase from S. Solfataricus, beta-glycosidase, has been

45

characterized (Haseltine, et al., 1999(a)).
Plant-derived polysaccharides are used in enormous

quantities as foods (Sugar) and, following conversion, in
other Specialty and value added chemicals. Such as ethanol.
Consequently, these materials are recognized as essential
and are traded as commodities. Indeed, key measures of
inflation are strongly influenced by the value assigned to

50

Such commodities. Sugar (glucose) is produced by biopro

cessing of plant Starch from plants including corn, Sugar
beets and Sugar cane. Incremental improvements in Sugar
production reflect two basic Strategies, increasing the yield
of polysaccharide on a per plant mass basis and increasing
the conversion of endogenous Starch into Sugar. Where the
former approach results from advances in plant breeding, the
latter approach initiated the introduction of microbial gene
products as cell-free bioprocessing components. Key among
these additives are two enzymes, alpha-amylase and gluco
amylase, which are employed as commodity materials.
Alpha-amylase is an endo-acting enzyme which debranches
Starch yielding dextrin. Glucoamylase is an exo-acting
enzyme which serially hydrolyzes dextrin subunits into free
glucose. Plant Starch hydrolysis requires hydration to enable

2
enzyme action, consequently the introduction of water is a
critical first Step and is conventionally performed by heating
and extrusion. Cost effective bioprocessing necessitates
rapid throughput therefore, a thermoStable alpha-amylase is
commonly added to enable immediate debranching of
hydrated starch. However, both the pH and the temperature
of the bioprocessing reactors must thereafter be adjusted to
create near-neutral and reduced temperatures to Support
activity of the commercial glucoamylase. As a result, a
Source of transgenic, thermostable glycosyl hydrolases
would be an important contribution to the Starch processing
industry due to their activity at high temperatures and
eXtreme Stability at room temperatures, which offers
extended Shelf life. Although glycosyl hydrolases occur
among the hyperthermophillic archaea (Costantino, et al.,
1990; Rolfsmeirand Blum, 1995; Haseltine, et al., 1999(a)),
their culture as a Source of enzyme is complicated by their
extreme growth requirements. Furthermore, expression of
archaeal enzymes in heterologous hosts is complicated by
the altered environment in which expression occurs and
difficulty with translation and post translational processing
(Trent, et al., 1991). Over production of archaeal proteins in
plants would require that the protein fold properly in plants
which, for thermostable proteins, may require chaperones
not normally present in plants. To date, no archaeal alpha
glucosidase genes have been cloned or expressed recombi
nantly.

55

60

65

The present invention relates to a novel nucleic acid
coding for a thermostable glycosyl hydrolase, alpha
glucosidase, from the archaeon SulfolobuS SolfatoricuS and
a novel enzyme coded by its gene, malA. It also relates to
bacteria and plants transformed with hyperthermophilic
alpha-glucosidase and a method for preparing the recombi
nant alpha-glucosidase by use of the Same. The present
invention further relates to a method of using the transgenic
thermostable glycosyl hydrolases for the bioprocessing of
plant carbohydrates.
The malA gene of the present invention has been
identified, cloned and expressed in bacteria and plants. The
distribution and associated activity of the malA gene in the
three most common members of the Sulfolobus genus have
been determined.

The purified alpha-glucosidase produced by the recom
binant malA gene, provides an extremely thermostable
enzyme which is able to hydrolyze a Surprisingly wide range
of polysaccharides to glucose. Substrates include Starch and
maltodextrins indicating that the enzyme acts as both an
alpha-amylase and an alpha-glucosidase. Additionally,
Sucrose is hydrolyzed to invert Sugar by the malA gene
product, indicating the enzyme is also a Sucrase.
Extracts of transgenic plants of the present invention
expressing thermostable glycosyl hydrolases have been pre
pared. The plant extracts are able to undergo “autohydroly
Sis' of plant polysaccharide into glucose and other SugarS.
The recombinant glycosyl hydrolases expressed in the trans
genic plants are nontoxic in plant tissues because the
enzymes are inactive at temperatures Supporting plant
growth and therefore do not significantly interfere with
normal metabolism in the living plant. Thus, regulated plant
promoters are not required and constitutive promoters are
Sufficient. When desired, the transgenic plant tissue can be
heated to activate the enzymes, causing in Situ processing of
Storage carbohydrates to glucose and other Small molecules
by the recombinant plant extract, itself. This obviates the

US 6,506,592 B1
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alpha-glucosidase (closed circles), and empty vector trans
formed plant (labeled). Glucose levels were determined
using the glucose oxidase assay.
FIGS. 8A, 8B and 8C are plots of recombinant alpha
glucosidase activity and protein content per milligram fresh
weight in leaves of T2 tobacco plants at 70, 95 and 116 days
after Seeding, respectively.
FIGS. 9A and 9B. 9A shows the bacterial expression
vector including the malA gene.9B is a Northern blot of the
malA region of the vector.
FIGS. 10A and 10B. 10A shows the plant expression
plasmid including the malA gene. 10B is a Northern blot of
the malA region of the plasmid.

3
need to add Separately produced commodity enzymes to
plant material, as is the current method used in industry.
Accordingly, this invention comprises the following
aspects:

1) An isolated nucleic acid molecule encoding thermo
Stable alpha-glucosidase comprising the nucleotide
sequence of SEQ ID NO:1.

2) An expression vector comprising the nucleotide
sequence of SEQ ID NO: 1.

3) Transformed host cells comprising the nucleotide
sequence of SEQ ID NO: 1.

4) Transformed host cells expressing the recombinant
amino acid sequence of SEQ ID NO:2.

5) Methods of preparing the transformed hosts of 4).
6) Methods for extracting and purifying heterologous,

15

thermostable glycosyl hydrolases from transformed
host cells.

leaves (closed circles) were determined from the same plant

7) Characterization of recombinant glycosyl hydrolase

at the indicated times after plant Seeding. Total leaf protein

enzymes, including their useful chemical and physical
properties and utility for industrial applications.

(open circles) was determined per leaf area. FIG. 11B shows

8) Novel recombinant enzyme of 7) comprising the amino
acid sequence of SEQ ID NO:2.

9) Transgenic plant cells expressing thermostable glyco
Syl hydrolases that are capable of autohydrolysis (in
Situ processing) of Substrate into glucose and other

25

Small molecules.
BRIEF DESCRIPTION OF THE DRAWINGS

FIGS. 1A and 1B are the malA coding region and a gene
construct containing the malA gene from Sulfolobus Solfa
taricus. The malA coding sequence plus 30 bp of the malA
promoter region was cloned into the Xho I/Bam HI site of
the plant expression vector pRTL2 between the enhanced
35S promoter and the 35S polyadenylation signal. The 3.5
kb Pst I fragment of the resulting plasmid was then cloned
into the multiple cloning site of the binary vector pPZP112
to produce the construct pPB709 for transformation into
plants.

35

40

among Sulfolobus species as determined by Southern blot.
FIGS. 4A and 4B show the pH optima of recombinant
alpha-glucosidase for maltose and glycogen hydrolysis.
FIGS. 5A and 5B show levels of thermostable glycosyl
hydrolases in transgenic tobacco transformants. FIG. 5A
ShowS levels of alpha-glucosidase activity in independent
transformed plants. FIG. 5B shows levels of beta
glycosidase activity in independent transformed plants.
FIG. 6 shows a densitometry tracing of a western blot of
malA plant extract and purified alpha-glucosidase.
FIGS. 7A and B show the release of glucose by transgenic
glycosyl hydrolases from exogenous and endogenous plant
carbohydrates. FIG. 7A. Glucose released by the alpha
glucosidase using an exogenous Soluble Starch as Substrate.

45

A 5% (w/v) solution of soluble starch was incubated at 80°
C. with no additions (closed circles), with a protein extract
from a plant transformed with an empty vector (open circles)
and with a protein extract from transformant MI52E con
taining the alpha-glucosidase (closed Squares). FIG. 7B.

60

Glucose released by glycosyl hydrolases using an endog
enous polysaccharide-enriched plant extract as Substrate.

65

Protein extracts were: beta-glycosidase (closed Squares),

levels of beta-glycosidase.
FIGS. 12A, 12B and 12C show the presence of glycosyl
hydrolases in transformed tobacco leaves. FIG. 12A shows
a colormetric western blot analysis of alpha-glucosidase in
transgenic plant leaves. Lane 1, E. coli-derived recombinant
alpha-glucosidase; lane 2, protein extract of transformant
MI52E.; lane 3, protein extract of plant transformed with an
empty vector. Samples for western blots were loaded in 20
tug amounts per lane. Blots were probed with rabbit anti
beta-glycosidase polyclonal antibodies. FIG. 12B shows a
colormetric Western blot analysis of beta-glycosidase in
plant leaves. Lane 1, protein extract of transformant JJ-6;
lane 2, protein extract of plant transformed with an empty
vector, lane 3, extract of E. coli containing puC19, lane 4,
E. coli-derived recombinant beta-glycosidase. FIG. 12C.
Immunoprecipitation of alpha-glucosidase activity from
transformant MI52E.

FIGS. 2A and 2B show the DNA sequence (SEQ ID
NO:1) and deduced, encoded amino acid sequence (SEQ ID
NO:2) of the malA gene.
FIGS. 3A and 3B show the distribution of malA DNA

FIGS. 11A and 11B show accumulation of recombinant

glycosyl hydrolase activities in aging transgenic tobacco
plants. FIG. 11A shows levels of alpha-glucosidase. Mean
enzyme specific activities representing Samples from five

50
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SUMMARY OF SEQUENCE LISTING

SEQ ID NO:1 is the nucleotide sequence for the malA
gene. SEQID NO:2 is the amino acid sequence for the malA
protein. SEQ ID NO:3 is the N-terminal amino acid
Sequence for alpha-glucosidase from S. Sulfataricus. SEQID
NO:4 is the amino acid Sequence for alpha-glucosidase
generated by chemical cleavage with cyanogen bromide.
DETAILED DESCRIPTION OF THE
INVENTION

The present invention relates to a novel nucleic acid
coding for a thermostable glycosyl hydrolase, alpha
glucosidase, from the archaeon SulfolobuS SolfatoricuS and
a novel enzyme coded by its gene, malA. It also relates to
bacteria and plants transformed with hyperthermophilic
alpha-glucosidase and a method for preparing the recombi
nant alpha-glucosidase by use of the Same. The present
invention further relates to a method of using the transgenic
thermostable glycosyl hydrolases for the bioprocessing of
plant carbohydrates.
Cloning, Characterization and Expression of malA Gene
Using gene-Specific PCR primerS derived from the alpha
glucosidase protein Sequence as probe to Screen a genomic
S. Solfataricus 98/2 phage lambda library, the malA gene of
the present invention has been cloned and characterized

(GenBank Accession No. AF042494). The nucleotide
sequence is set forth as SEQ ID NO:1 (FIG. 2), and the

US 6,506,592 B1
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an acid-resistant thermotolerant alpha-amylase (amy A)
which retains full function after one week of 80 C. at pH 3
(Haseltine, et al., 1996; Haseltine, et al., 1999(a)). Two other
activities have been characterized: a) a cell associated alpha
glucosidase or alpha-glucosidase (malA) with a temperature
optimum of 105 C. which converts dextrins and other
alpha-linked polymers into glucose (Rolfsmeier and Blum,
1995), and b) a beta-glycosidase (lacs) which converts
beta-linked disaccharides into glucose (Haseltine, et al.,
1999(b)). Both the alpha-glucosidase and the beta

S

amino acid sequence is set forth as SEQ ID NO:2 (FIG. 2).

It has been found that the malA sequence comprises 2,083
bp encoding a protein of 693 amino acids.
In carrying out this invention, isolation and purification of
DNA carrying the genetic information of the thermostable
glycosyl hydrolases from Sulfolobus Solfataricus was per
formed by conventional means. For instance, restriction
digestion and ligation of DNA and DNA sequence analysis

were performed as described previously. (Blum, et al., 1992;
Rockabrand and Blum, 1995; Haseltine, et al., (1999(a)).

Insertion of chromosomal DNA into vector DNA was

performed by digesting the chromosomal DNA and plasmid
DNA with restriction enzymes to yield chromosomal DNA
and plasmid DNA fragments and treating the mixture of
those with DNA ligases.
The resulting plasmids were introduced into a bacterial
host and/or used to transform Agrobacterium tumefacienS by

15

Definitions

freeze-thaw method (An, et al., 1988). The transformed A.

tumefacienS was used to transform plants by the leaf disc
method of Horsch, et al., 1985. All manipulations of
Escherichia coli were as described previously in
Rockabrand, et al., 1995.

The production of the recombinant enzymes of this inven
tion were conducted by over expression in E. coli. ASSayS
for alpha-glucosidase activity were performed with para
nitrophe nyl-alpha-D-glucopy rano Side

25

O

methylumbelliferyl-alpha-D-glucoside. Assays for hydroly
sis of Substrate and detection of glucose were monitored by
means known in the art. Purification of the recombinant

al., 1995.

35

engineering (Sommerville and Sommerville, 1999). Meta

bolic engineering of plant biochemistry includes an expand
ing list of Secondary metabolites and modified pathway end
products ranging from lipids to Small molecules. Balanced
against this goal are the physiological consequences result
ing from the accumulation of foreign, and possibly toxic,
compounds. Clearly improvements in bioprocessing will
lead to further improvements in agricultural proceSS eco
nomics and create new opportunities to increase the types
and amounts of derivative materials. One approach for
improving bioprocessing is to eliminate the need to add
commodity enzymes for starch hydrolysis. To fit the current
technology, however, this necessitates the use of thermotol
erant catalysts. In addition, other plant polysaccharides Such
as beta-linked polymeric Sugars are not currently used in
commercial processes.
Archaea have recently been recognized as a distinct
branch of prokaryotes, as distantly related to bacteria as they

40

45
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hyperthermophiles, the methanogens and the halophiles,

60

The present invention relates to the hyperthermophiles
which produce numerous proteins of industrial interest

(Cowan, 1992). Key among these activities are those which
promote the hydrolysis of plant polysaccharides (Sunna,
1997). Several representative activities from the hyperther
mophile SulfolbOuS SOlfataricus, are characterized herein at
both the genetic and functional level. S. SolfataricuS Secretes

transcribed and/or translated to produce the mRNA for
and/or the polypeptide or a fragment thereof. The anti-Sense
Strand is the complement of Such a nucleic acid, and the
encoding Sequence can be deduced therefrom.
As used herein, “expression system” refers to DNA
Sequences containing a desired coding Sequence and control
Sequences in operable linkage, So that hosts transformed
with these Sequences are capable of producing the encoded
proteins. In order to effect transformation, the expression
System may be included on a vector, however, the expression
System may then also be integrated into the host chromo
SOC.

are to eukaryotic organisms. (Woese, et al., 1990; Whitman,
et al., 1999). They include three dominant biotypes; the
each is associated with distinct and extreme environments.

The present invention employs the following definitions.
AS used herein, “autodigestion' and “autohydrolysis” is
the ability of transgenic plant tissue which encodes for and
expresses heterologous thermostable glycosyl hydrolase to
undergo hydrolysis of Substrate into glucose and other Small
molecules when Subjected to heat.
AS used herein, “alpha-glycosidase' refers to an enzyme
which Splits polysaccharides, through the hydrolysis of
glycosidic bonds.
“Encode”. A polynucleotide is said to “encode” a
polypeptide if, in its native State or when manipulated by
methods well known to those skilled in the art, it can be

enzyme to apparent homogeneity employed heat fraction
ation of clarified cell Sonicates followed by anion-exchange
fast protein liquid chromatography and gel filtration fast
protein liquid chromatography as described in Rolfsmeier, et
Autodigestion of Plant Tissue. Using Hyperthermophilic
Glycosyl Hydrolases
New Strategies to accomplish improved plant bioprocess
ing rest on the merging technology of plant metabolic

glycosidase have been Surprisingly discovered to have broad
Substrate preferences. It has been unexpectedly determined
the transgenic plants expressing these last two activities are
able, upon heating at elevated temperatures, to undergo a
process of autodigestion converting polysaccharides into
monosaccharides in a Single Step.
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AS used herein, “gene’ refers to a DNA sequence that
encodes a recoverable bioactive polypeptide or precursor.
The polypeptide can be encoded by a full-length gene
Sequence or any portion of the coding Sequence So long as
the enzyme activity is maintained.
AS used herein, “glycosyl hydrolase' refers to enzymes
which hydrolyze substances linked by glycosyl bonds, for
example, polysaccharides.
AS used herein, "hyperthermophilic' refers to an organ
ism capable of growth above 70 degrees C., or proteins
derived from Such an organism.
“Isolated” or “substantially pure”. An "isolated” or “sub

Stantially pure' nucleic acid (e.g., an RNA, DNA or a mixed
polymer) or protein is one which is Substantially separated

from other cellular components which naturally accompany
a native Sequence or protein, e.g., ribosomes, polymerases,
many other Sequences and proteins. The term embraces a
nucleic acid Sequence or protein which has been removed
from its naturally occurring environment, and includes
recombinant or cloned DNA isolates and chemically syn
thesized analogs or analogs biologically Synthesized by
heterologous Systems.
“malA Allele” refers to normal alleles of the malA gene.
“malA Locus”, “malA Gene”, “malA Nucleic Acids” or

“malA Polynucleotide” each refer to polynucleotides, all of
which are in the malA region, that are likely to be expressed
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in normal tissue. The malA locus is intended to include

fications include, for example, labels, methylation, Substi
tution of one or more of the naturally occurring nucleotides
with an analog, internucleotide modifications Such as

coding Sequences, intervening Sequences and regulatory
elements controlling transcription and/or translation. The

uncharged linkages (e.g., methyl phosphonates,
phosphotriesters, phosphoramidates, carbamates, etc.),
charged linkage S (e.g., phosphor othioate S,
phosphorodithioates, etc.), pendent moieties (e.g.,
polypeptides), intercalators (e.g., acridine, psoralen, etc.),
chelators, alkylators, and modified linkages (e.g., alpha
anomeric nucleic acids, etc.). Also included are synthetic

malA locus is intended to include all allelic variations of the

DNA sequence.
These terms, when applied to a nucleic acid, refer to a
nucleic acid which encodes an archaeal malA polypeptide,
fragment, homolog or Variant, including, e.g., protein
fusions or deletions. The nucleic acids of the present inven
tion will possess a Sequence which is either derived from, or
Substantially Similar to a natural malA-encoding gene or one
having Substantial homology with a natural malA-encoding
gene or a portion thereof.
The malA gene or nucleic acid includes normal alleles of
the malA gene, including Silent alleles having no effect on
the amino acid Sequence of the malA polypeptide as well as
alleles leading to amino acid Sequence variants of the malA
polypeptide that do not Substantially affect its function.
These terms also include alleles having one or more muta
tions which adversely affect the function of the malA
polypeptide. A mutation may be a change in the malA
nucleic acid Sequence which produces a deleterious change
in the amino acid Sequence of the malA polypeptide, result
ing in partial or complete loSS of malA function, or may be
a change in the nucleic acid Sequence which results in the
loSS of effective malA expression or the production of
aberrant forms of the malA polypeptide.
The malA nucleic acid may be that shown in SEQ ID
NO:1 or it may be an allele as described above or a variant
or derivative differing from that shown by a change which
is one or more of addition, insertion, deletion and Substitu
tion of one or more nucleotides of the Sequence shown.

Changes to the nucleotide Sequence may result in an amino
acid change at the protein level, or not, as determined by the
genetic code.
Thus nucleic acids according to the present invention may
include a Sequence different from the Sequence shown in
SEQ ID NO:1 yet encode a polypeptide with..the same amino
acid sequence as shown in SEQ ID NO:2. That is, nucleic
acids of the present invention include Sequences which are
degenerate as a result of the genetic code. On the other hand,
the encoded polypeptide may comprise an amino acid
Sequence which differs by one or more amino acid residues
from the amino acid sequence shown in SEQ ID NO:2.
Nucleic acid encoding a polypeptide which is an amino acid
Sequence variant, derivative or allele of the amino acid
sequence shown in SEQ ID NO:2 is also provided by the
present invention.

The malA gene also refers to (a) any DNA sequence that
(i) hybridizes to the complement of the DNA sequences that

molecules that mimic polynucleotides in their ability to bind
to a designated Sequence via hydrogen bonding and other

chemical interactions. Such molecules are known in the art
15

origin which, by virtue of its origin or manipulation, 1) is not
asSociated with all or a portion of a polynucleotide with
25

with USubstituted for T.
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readily appreciated by those skilled in the art. Such modi

Therefore, recombinant nucleic acids comprising
Sequences otherwise not naturally occurring are provided by
this invention. Although the wild-type Sequence may be
employed, it will often be altered, e.g., by deletion, Substi
tution or insertion. cDNA or genomic libraries of various
types may be Screened as natural Sources of the nucleic acids
of the present invention, or Such nucleic acids may be
provided by amplification of Sequences resident in genomic
DNA or other natural sources, e.g., by PCR. The choice of
cDNA libraries normally corresponds to a tissue Source
which is abundant in mRNA for the desired proteins. Phage
libraries are normally preferred, but other types of libraries
may be used. Clones of a library are spread onto plates,
transferred to a Substrate for Screening, denatured and
probed for the presence of desired Sequences.
The DNA sequences used in this invention will usually

comprise at least about five codons (15 nucleotides), more

50
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(Ausubel, et al., 1992) and (ii) encodes a gene product

non-natural or derivatized nucleotide bases, as will be

which it is associated in nature; 2) is linked to a polynucle
otide other than that to which it is linked in nature; or 3) does
not occur in nature. Where nucleic acid according to the
invention includes RNA, reference to the Sequence shown
should be construed as reference to the RNA equivalent,

under highly stringent conditions (Ausubel, et al., 1992) and
(ii) encodes a gene product functionally equivalent to malA,
or (b) any DNA sequence that (i) hybridizes to the comple

functionally equivalent to malA. The invention also includes
nucleic acid molecules that are the complements of the
Sequences described herein.
The polynucleotide compositions of this invention
include RNA, cDNA, genomic DNA, synthetic forms, and
mixed polymers, both Sense and antisense Strands, and may
be chemically or biochemically modified or may contain

molecule.

The present invention provides recombinant nucleic acids
comprising all or part of the malA region. The recombinant
construct may be capable of replicating autonomously in a
host cell. Alternatively, the recombinant construct may
become integrated into the chromosomal DNA of the host
cell. Such a recombinant polynucleotide comprises a poly
nucleotide of genomic, cDNA, Semi-Synthetic, or Synthetic

encode the amino acid sequence set forth in SEQ ID NO:2

ment of the DNA sequences that encode the amino acid
sequence set forth in SEQ ID NO:2 under less stringent
conditions, Such as moderately Stringent conditions

and include, for example, those in which peptide linkages
Substitute for phosphate linkages in the backbone of the

60

usually at least about 7-15 codons, and most preferably, at
least about 35 codons. This number of nucleotides is usually
about the minimal length required for a Successful probe that
would hybridize Specifically with an malA-encoding
Sequence. In this context, oligomers of as low as 8
nucleotides, more generally 8-17 nucleotides, can be used
for probes, especially in connection with chip technology.
Techniques for nucleic acid manipulation are described
generally, for example, in Sambrook, et al., 1989 or Ausubel,
et al., 1992. Reagents useful in applying Such techniques,
Such as restriction enzymes and the like, are widely known
in the art and commercially available from Such vendors as
New England BioLabs, Boehringer Mannheim, Amersham,
Promega, U.S. Biochemicals, New England Nuclear, and a
number of other Sources. The recombinant nucleic acid
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Sequences used to produce fusion proteins of the present
invention may be derived from natural or Synthetic
Sequences. Many natural gene Sequences are obtainable
from various cDNA or from genomic libraries using appro
priate probes. See, GenBank, National Institutes of Health.
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AS used herein, “operably linked” refers to a juxtaposition
wherein the components So described are in a relationship
permitting them to function in their intended manner. For
example, a promoter is linked to a coding Sequence if the
promoter affects its transcription or expression.
AS used herein, a "portion' of the malA locus or region or
allele is defined as having a minimal size of at least about
eight nucleotides, or preferably about 15 nucleotides, or
more preferably at least about 21 nucleotides, and may have

hydrophobicity, hydrophilicity, and/or the amphipathic
nature of the residues involved. Preferred Substitutions are

ones which are conservative, that is, one amino acid is

a minimal size of at least about 40 nucleotides. This defi

nition includes all sizes in the range of 8–40 nucleotides as
well as greater than 40 nucleotides. Thus, this definition
includes nucleic acids of 8, 12, 15, 20, 25, 40, 60, 80, 100,

200, 300, 400, 500 nucleotides, or nucleic acids having any

number of nucleotides within these ranges of values (e.g., 9,
10, 11, 16, 23, 30, 38, 50, 72, 121, etc., nucleotides), or

15

nucleic acids having more than 500 nucleotides, or any
number of nucleotides between 500 and the number shown

in SEQ ID NO:1. The present invention includes all novel
nucleic acids having at least 8 nucleotides derived from SEQ
ID NO:1, its complement or functionally equivalent nucleic
acid Sequences. The present invention does not include
nucleic acids which exist in the prior art. That is, the present
invention includes all nucleic acids having at least 8 nucle
otides derived from SEQ ID NO:1 with the proviso that it
does not include nucleic acids existing in the prior art.
“malA protein' or “malA polypeptide” refers to a protein
or polypeptide encoded by the malA locus, variants or
fragments thereof. The term “polypeptide' refers to a poly
mer of amino acids and its equivalent and does not refer to
a Specific length of the product; thus, peptides, oligopeptides
and proteins are included within the definition of a polypep
tide. This term also does not refer to, or exclude modifica
tions of the polypeptide, for example, glycosylations,
acetylations, phosphorylations, and the like. Included within
the definition are, for example, polypeptides containing one

generally understood in the art (Kyte and Doolittle, 1982).

25

hydrophilicity in designing polypeptides is further discussed
in U.S. Pat. No. 5,691,198.
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should be noted that throughout this disclosure, if it is
Simply Stated that “stringent conditions are used that is

meant to be read as “high Stringency conditions are used.)
50

Since such indications identify neutral DNA polymorphisms
as well as mutations, these indications need further analysis
to demonstrate detection of an malA or lacS Susceptibility
allele.
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one amino acid for another at one or more Sites within the

protein, and may be designed to modulate one or more
properties of the polypeptide, Such as Stability against pro
teolytic cleavage, without the loSS of other functions or
properties. Amino acid Substitutions may be made on the
basis of Similarity in polarity, charge, Solubility,

The length of polypeptide Sequences compared for
homology will generally be at least about 16 amino acids,
usually at least about 20 residues, more usually at least about
24 residues, typically at least about 28 residues, and pref
erably more than about 35 residues.
“Probes”. Polynucleotide sequences associated with malA
or lacS alleles are detected by hybridization with a poly
nucleotide probe which forms a stable hybrid with that of the
target Sequence, under highly Stringent to moderately Strin
gent hybridization and wash conditions. If it is expected that
the probes will be perfectly complementary to the target
Sequence, high Stringency conditions will be used. Hybrid
ization Stringency may be lessened if Some mismatching is
expected, for example, if variants are expected with the
result that the probe will not be completely complementary.
Conditions are chosen which rule out nonspecific/

adventitious bindings, that is, which minimize noise. (It

retrieved by antisera to the malA protein(s).

The malA polypeptide may be that shown in SEQ ID
NO:2 which may be in isolated and/or purified form, free or
substantially free of material with which it is naturally
asSociated. The polypeptide may, if produced by expression
in a prokaryotic cell or produced Synthetically, lack native
post-translational processing, Such as glycosylation.
Alternatively, the present invention is also directed to
polypeptides which are Sequence variants, alleles or deriva
tives of the malA polypeptide. Such polypeptides may have
an amino acid Sequence which differs from that Set forth in
SEQ ID NO:2 by one or more of addition, Substitution,
deletion or insertion of one or more amino acids, provided
Such polypeptides have malA function.
Substitutional variants typically contain the exchange of

Alternatively, the Substitution of like amino acids can be
made effectively on the basis of hydrophilicity. The impor
tance of hydrophilicity in conferring interactive biological

function of a protein is generally understood in the art (U.S.
Pat. No. 4,554,101). The use of the hydrophobic index or

or more analogs of an amino acid (including, for example,
unnatural amino acids, etc.), polypeptides with Substituted
linkages as well as other modifications known in the art,
both naturally and non-naturally occurring. Ordinarily, Such
polypeptides will be at least about 50% homologous to the
native malA sequence, preferably in excess of about 90%,
and more preferably at least about 95% homologous. Also
included are proteins encoded by DNA which hybridizes
under high or low Stringency conditions, to malA-encoding
nucleic acids and closely related polypeptides or proteins

replaced with one of Similar shape and charge. Conservative
Substitutions are well known in the art and typically include
Substitutions within the following groups: glycine, alanine;
Valine, isoleucine, leucine; aspartic acid, glutamic acid;
asparagine, glutamine, Serine, threonine; lysine, arginine;
and tyrosine, phenylalanine.
Certain amino acids may be Substituted for other amino
acids in a protein Structure without appreciable loSS of
interactive binding capacity with Structures Such as, for
example, antigen-binding regions of antibodies or binding
Sites on Substrate molecules or binding Sites on proteins
interacting with the malA polypeptide. Since it is the inter
active capacity and nature of a protein which defines that
protein's biological functional activity, certain amino acid
Substitutions can be made in a protein Sequence, and its
underlying DNA coding Sequence, and nevertheless obtain a
protein with like properties. In making Such changes, the
hydropathic index of amino acid Side chains may be con
sidered. The importance of the hydropathic amino acid index
in conferring interactive biological function on a protein is
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Probes for malA or lacS alleles may be derived from the
Sequences of the respective region, its cDNA, functionally
equivalent Sequences, or the complements thereof. The
probes may be of any Suitable length, which span all or a
portion of the respective region, and which allow specific
hybridization to the region. If the target Sequence contains a
Sequence identical to that of the probe, the probes may be
Short, e.g., in the range of about 8-30 base pairs, Since the
hybrid will be relatively stable under even highly stringent
conditions. If Some degree of mismatch is expected with the
probe, i.e., if it is suspected that the probe will hybridize to
a variant region, a longer probe may be employed which
hybridizes to the target Sequence with the requisite Speci
ficity.
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The probes will include an isolated polynucleotide
attached to a label or reporter molecule and may be used to
isolate other polynucleotide Sequences, having Sequence
Similarity by Standard methods. For techniques for preparing
and labeling probes See, e.g., Sambrook et al., 1989 or
Ausubel et al., 1992. Other similar polynucleotides may be
Selected by using homologous polynucleotide S.
Alternatively, polynucleotides encoding these or Similar
polypeptides may be Synthesized or Selected by use of the
redundancy in the genetic code. Various codon Substitutions
may be introduced, e.g., by Silent changes (thereby produc
ing various restriction sites) or to optimize expression for a
particular System. Mutations may be introduced to modify
the properties of the polypeptide, perhaps to change the
polypeptide degradation or turnover rate.
Probes comprising Synthetic oligonucleotides or other
polynucleotides of the present invention may be derived
from naturally occurring or recombinant Single- or double
Stranded polynucleotides, or be chemically Synthesized.
Probes may also be labeled by nick translation, Klenow
fill-in reaction, or other methods known in the art.
Portions of the polynucleotide Sequence having at least
about eight nucleotides, usually at least about 15
nucleotides, and fewer than about 9 kb, usually fewer than
about 1.0 kb, from a polynucleotide Sequence encoding
malA are preferred as probes. This definition therefore
includes probes of sizes 8 nucleotides through 9000 nucle
otides. Thus, this definition includes probes of 8, 12, 15, 20,

12
include, for example, acetylation, carboxylation,
phosphorylation, glycosylation, ubiquitination, labeling,
e.g., with radionuclides, and Various enzymatic
modifications, as will be readily appreciated by those well
skilled in the art. A variety of methods for labeling polypep
tides and of Substituents or labels useful for Such purposes
are well known in the art, and include radioactive isotopes

Such as P, ligands which bind to labeled antiligands (e.g.,
antibodies), fluorophores, chemiluminescent agents,

15
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25, 40, 60, 80, 100, 200, 300, 400 or 500 nucleotides or

probes having any number of nucleotides within these

ranges of values (e.g., 9, 10, 11, 16, 23, 30, 38, 50, 72, 121,
etc., nucleotides), or probes having more than 500
nucleotides, or any number of nucleotides between 500 and
the number of nucleotides in SEQID NO:1. The probes may
also be used to determine whether mRNA encoding malA is
present in a cell or tissue. The present invention includes all
novel probes having at least 8 nucleotides derived from SEQ
ID NO:1, its complement or functionally equivalent nucleic
acid Sequences. The present invention does not include
probes which exist in the prior art. That is, the present
invention includes all probes having at least 8 nucleotides
derived from SEQID NO:1 with the proviso that they do not
include probes existing in the prior art.
Similar considerations and nucleotide lengths are also
applicable to primers which may be used for the amplifica
tion of all or part of the malA gene. Thus, a definition for
primers includes primers of 8, 12, 15, 20, 25, 40, 60,80, 100,
200, 300, 400, 500 nucleotides, or primers having any

number of nucleotides within these ranges of values (e.g., 9,
10, 11, 16, 23, 30, 38, 50, 72, 121, etc. nucleotides), or

primerS having more than 500 nucleotides, or any number of
nucleotides between 500 and 9000. The primers may also be
used to determine whether mRNA encoding malA is present
in a cell or tissue. The present invention includes all novel
primerS having at least 8 nucleotides derived from the malA
locus for amplifying the malA gene, its complement or
functionally equivalent nucleic acid Sequences. The present
invention does not include primers which exist in the prior
art. That is, the present invention includes all primerS having
at least 8 nucleotides with the proviso that it does not include
primers existing in the prior art.
“Protein modifications or fragments” are provided by the
present invention for malA polypeptides or fragments
thereof which are Substantially homologous to primary
Structural Sequence but which include, e.g., in Vivo or in
vitro chemical and biochemical modifications or which

incorporate unusual amino acids. Such modifications

35

40

45

enzymes, and antiligands which can Serve as Specific bind
ing pair members for a labeled ligand. The choice of label
depends on the Sensitivity required, ease of conjugation with
the primer, Stability requirements, and available instrumen
tation. Methods of labeling polypeptides are well known in
the art. See Sambrook et al., 1989 or Ausubel et al., 1992.
Besides Substantially full-length polypeptides, the present
invention provides for biologically active fragments of the
polypeptides. Significant biological activities include
ligand-binding, enzymatic activity and other biological
activities characteristic of malA polypeptides.
The present invention also provides for fusion
polypeptides, comprising malA polypeptides and fragments.
Homologous polypeptides may be fusions between two or
more malA polypeptide Sequences or between the Sequences
of malA and a related protein. Likewise, heterologous
fusions may be constructed which would exhibit a combi
nation of properties or activities of the derivative proteins.
For example, ligand-binding or other domains may be
“swapped” between different new fusion polypeptides or
fragments. Such homologous or heterologous fusion
polypeptides may display, for example, altered Strength or
Specificity of binding. Fusion partners include
immunoglobulins, bacterial f-galactosidase, trpE, protein A,
f-lactamase, alpha amylase, alcohol dehydrogenase and
yeast alpha mating factor. See Godowski et al., 1988.
Fusion proteins will typically be made by either recom
binant nucleic acid methods, as described below, or may be
chemically Synthesized. Techniques for the Synthesis of
polypeptides are described, for example, in Merrifield, 1963.
“Protein purification', unless otherwise specifically
described or incorporated herein, refers to various methods
for the isolation of the malA and lacS polypeptides from
other biological material, Such as from cells transformed
with recombinant nucleic acids encoding malA or lacS, and
are well known in the art. For example, Such polypeptides
may be purified by immunoaffinity chromatography
employing, e.g., the antibodies provided by the present
invention. Various methods of protein purification are well
known in the art, and include those described in Deutscher,
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1990 and Scopes, 1982.
The terms “isolated”, “substantially pure”, and “substan
tially homogeneous” are used interchangeably to describe a
protein or polypeptide which has been Separated from com
ponents which accompany it in its natural State. A mono
meric protein is Substantially pure when at least about 60 to
75% of a Sample exhibits a Single polypeptide Sequence. A
Substantially pure protein will typically comprise about 60 to
90% w/w of a protein sample, more usually about 95%, and
preferably will be over about 99% pure. Protein purity or
homogeneity may be indicated by a number of means well
known in the art, Such as polyacrylamide gel electrophoresis
of a protein Sample, followed by Visualizing a single
polypeptide band upon Staining the gel. For certain
purposes, higher resolution may be provided by using HPLC
or other means well known in the art which are utilized for
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purification.
malA and lacS proteins are Substantially free of naturally
asSociated components when they are separated from the
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mining homology herein, the percent homology refers to the
Shorter of the two Sequences being compared. If any one
region is shown in different alignments with differing per
cent identities, the alignments which yield the greatest
homology are to be used.

13
native contaminants which accompany them in their natural
State. Thus, a polypeptide which is chemically Synthesized
or synthesized in a cellular system different from the cell
from which it naturally originates will be substantially free
from its naturally associated components. A protein may
also be rendered Substantially free of naturally associated
components by isolation, using protein purification tech
niques well known in the art.
A polypeptide produced as an expression product of an
isolated and manipulated genetic Sequence is an "isolated
polypeptide', as used herein, even if expressed in a homolo
gous cell type. Synthetically made forms or molecules
expressed by heterologous cells are inherently isolated mol
ecules.
"Recombinant nucleic acid' is a nucleic acid which is not

naturally occurring, or which is made by the artificial
combination of two otherwise Separated Segments of
Sequence. This artificial combination is often accomplished
by either chemical Synthesis means, or by the artificial
manipulation of isolated Segments of nucleic acids, e.g., by
genetic engineering techniques. Such is usually done to
replace a codon with a redundant codon encoding the same
or a conservative amino acid, while typically introducing or
removing a Sequence recognition site. Alternatively, it is
performed to join together nucleic acid Segments of desired
functions to generate a desired combination of functions.
“Substantial homology or similarity”. A nucleic acid or

Alternatively, Substantial homology or (similarity) exists

when a nucleic acid or fragment thereof will hybridize to

another nucleic acid (or a complementary Strand thereof)

15

about 36 or more nucleotides.
25

fragment thereof is “substantially homologous” (“or Sub
Stantially similar') to another if, when optimally aligned
(with appropriate nucleotide insertions or deletions) with the
other nucleic acid (or its complementary Strand), there is

nucleotide sequence identity in at least about 60% of the
nucleotide bases, usually at least about 70%, more usually at
least about 80%, preferably at least about 90%, and more
preferably at least about 95-98% of the nucleotide bases.
To determine homology between two different nucleic
acids, the percent homology is to be determined using the
BLASTN program “BLAST 2 sequences”. This program is
available for public use from the National Center for Bio
technology Information (NCBI) over the Internet (http://
www.ncbi.nlm.nih.gov/gorf/bl2.html) (Altschul et al.,
1997). The parameters to be used are whatever combination
of the following yields the highest calculated percent homol
ogy (as calculated below) with the default parameters shown
in parentheses:
Program-blastin
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Matrix-O BLOSUM62

Reward for a match-0 or 1 (1)
Penalty for a mismatch-0, -1, -2 or -3 (-2)
Open gap penalty—0, 1, 2, 3, 4 or 5 (5)
Extension gap penalty-0 or 1 (1)
Gap x dropoff 0 or 50 (50)
Expect-10
Along with a variety of other results, this program shows
a percent identity across the complete Strands or acroSS
regions of the two nucleic acids being matched. The pro
gram ShowS as part of the results an alignment and identity
of the two Strands being compared. If the Strands are of equal
length then the identity will be calculated acroSS the com
plete length of the nucleic acids. If the Strands are of unequal
lengths, then the length of the shorter nucleic acid is to be
used. If the nucleic acids are quite Similar acroSS a portion
of their sequences but different across the rest of their
sequences, the blastin program “BLAST 2 Sequences” will
show an identity acroSS only the Similar portions, and these
portions are reported individually. For purposes of deter

under Selective hybridization conditions, to a Strand, or to its
complement. Selectivity of hybridization exists when
hybridization which is substantially more selective than total
lack of Specificity occurs. Typically, Selective hybridization
will occur when there is at least about 55% homology over
a stretch of at least about 14 nucleotides, preferably at least
about 65%, more preferably at least about 75%, and most
preferably at least about 90%. See, Kanehisa, 1984. The
length of homology comparison, as described, may be over
longer Stretches, and in certain embodiments will often be
over a stretch of at least about nine nucleotides, usually at
least about 20 nucleotides, more usually at least about 24
nucleotides, typically at least about 28 nucleotides, more
typically at least about 32 nucleotides, and preferably at least
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Nucleic acid hybridization will be affected by Such con
ditions as Salt concentration, temperature, or organic
Solvents, in addition to the base composition, length of the
complementary Strands, and the number of nucleotide base
mismatches between the hybridizing nucleic acids, as will
be readily appreciated by those skilled in the art. Stringent
temperature conditions will generally include temperatures
in excess of 30° C., typically in excess of 37 C., and
preferably in excess of 45 C. Stringent salt conditions will
ordinarily be less than 1000 mM, typically less than 500
mM, and preferably less than 200 mM. However, the com
bination of parameters is much more important than the
measure of any Single parameter. The Stringency conditions
are dependent on the length of the nucleic acid and the base
composition of the nucleic acid and can be determined by
techniques well known in the art. See, e.g., Wetmur and
Davidson, 1968.

Probe Sequences may also hybridize Specifically to duplex
DNA under certain conditions to form triplex or other higher
order DNA complexes. The preparation of such probes and
suitable hybridization conditions are well known in the art.
The terms “substantial homology” or “substantial
identity”, when referring to polypeptides, indicate that the
polypeptide or protein in question exhibits at least about
30% identity with an entire naturally-occurring protein or a
portion thereof, usually at least about 70% identity, more
usually at least about 80% identity, preferably at least about
90% identity, and more preferably at least about 95%
identity.
Homology, for polypeptides, is typically measured using
Sequence analysis Software. See, e.g., the Sequence Analysis
Software Package of the Genetics Computer Group, Uni
versity of Wisconsin Biotechnology Center, 910 University
Avenue, Madison, Wis. 53705. Protein analysis software
matches Similar Sequences using measures of homology
assigned to various Substitutions, deletions and other modi
fications. Conservative Substitutions typically include Sub
Stitutions within the following groups: glycine, alanine;
Valine, isoleucine, leucine; aspartic acid, glutamic acid;
asparagine, glutamine, Serine, threonine; lysine, arginine;
and phenylalanine, tyrosine.
“Substantially similar function” refers to the function of a
modified nucleic acid or a modified protein, with reference
to the wild-type malA or lacS nucleic acid or wild-type malA
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or lacS polypeptide. The modified polypeptide will be
Substantially homologous to the wild-type polypeptide and
will have substantially the same function. The modified
polypeptide may have an altered amino acid Sequence and/or
may contain modified amino acids. In addition to the Simi
larity of function, the modified polypeptide may have other
useful properties, Such as a longer half-life. The Similarity of

Polynucleotide constructs prepared for introduction into a
prokaryotic or eukaryotic host may comprise a replication
System recognized by the host, including the intended poly
nucleotide fragment encoding the desired polypeptide, and
will preferably also include transcription and translational
initiation regulatory Sequences operably linked to the
polypeptide encoding Segment. Expression vectors may
include, for example, an origin of replication or autono

function (activity) of the modified polypeptide may be

mously replicating sequence (ARS) and expression control

Substantially the same as the activity of the wild-type
polypeptide. Alternatively, the Similarity of function

(activity) of the modified polypeptide may be higher than the

activity of the wild-type polypeptide. The modified polypep
tide is Synthesized using conventional techniques, or is
encoded by a modified nucleic acid and produced using
conventional techniques. The modified nucleic acid is pre
pared by conventional techniques. A nucleic acid with a
function Substantially similar to the wild-type gene function
produces the modified protein described above.
As used herein, “thermostable” when referring to an
enzyme means an enzyme which can function at high
temperatures and is stable to heat, heat resistant, and will not
denature at high temperatures.
A polypeptide “fragment”, “portion' or “segment' is a
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Sambrook et al., 1989 or Ausubel et al., 1992.

Stretch of amino acid residues of at least about five to Seven

contiguous amino acids, often at least about Seven to nine
contiguous amino acids, typically at least about nine to 13
contiguous amino acids and, most preferably, at least about
20 to 30 or more contiguous amino acids.
The polypeptides of the present invention, if Soluble, may
be coupled to a Solid-phase Support, e.g., nitrocellulose,

25

nylon, column packing materials (e.g., Sepharose beads),

magnetic beads, glass Wool, plastic, metal, polymer gels,
cells, or other Substrates. Such Supports may take the form,
for example, of beads, Wells, dipsticks, or membranes.
The practice of the present invention employs, unless
otherwise indicated, conventional techniques of chemistry,
molecular biology, microbiology, recombinant DNA,
genetics, and immunology. See, e.g., Maniatis et al., 1982;
Sambrook et al., 1989; Ausubel et al., 1992; Glover, 1985;
Anand, 1992; Guthrie and Fink, 1991.

Sequences, a promoter, an enhancer and necessary proceSS
ing information sites, Such as ribosome-binding Sites, RNA
Splice Sites, polyadenylation sites, transcription terminator
Sequences, and mRNA Stabilizing Sequences. Such vectors
may be prepared by means of Standard recombinant tech
niques well known in the art and discussed, for example, in

35

An appropriate promoter and other necessary vector
Sequences will be Selected So as to be functional in the host,
and may include, when appropriate, those naturally associ
ated with the malA gene. Examples of workable combina
tions of cell lines and expression vectors are described in
Sambrook et al., 1989 or Ausubel et al., 1992; see also, e.g.,
Metzger et al., 1988. Many useful vectors are known in the
art and may be obtained from Such vendors as Stratagene,
New England Biolabs, Promega Biotech, and others. Pro
moterS Such as the trip, lac and phage promoters, tRNA
promoters and glycolytic enzyme promoters may be used in
prokaryotic hosts. Useful yeast promoters include promoter
regions for metallothionein, 3-phosphoglycerate kinase or
other glycolytic enzymes Such as enolase or glyceraldehyde
3-phosphate dehydrogenase, enzymes responsible for mal
tose and galactose utilization, and others. Vectors and pro
moters Suitable for use in yeast expression are further
described in Hitzeman et al., EP 73,675A. Appropriate
non-native mammalian promoters might include the early

and late promoters from SV40 (Fiers et al., 1978) or pro
moters derived from murine Molony leukemia virus, mouse
tumor virus, avian Sarcoma viruses, adenovirus II, bovine
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papilloma virus or polyoma. Insect promoters may be
derived from baculovirus. In addition, the construct may be

Preparation of Recombinant or Chemically Synthesized

joined to an amplifiable gene (e.g., DHFR) So that multiple

Nucleic Acids: Vectors, Transformation, Host Cells

copies of the gene may be made. For appropriate enhancer
and other expression control Sequences, See also Enhancers
and Eukaryotic Gene Expression, Cold Spring Harbor Press,

Large amounts of the polynucleotides of the present
invention may be produced by replication in a Suitable host
cell. Natural or Synthetic polynucleotide fragments coding
for a desired fragment will be incorporated into recombinant
polynucleotide constructs, usually DNA constructs, capable
of introduction into and replication in a prokaryotic or
eukaryotic cell. Usually the polynucleotide constructs will
be Suitable for replication in a unicellular host, Such as yeast
or bacteria, but may also be intended for introduction to
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While Such expression vectors may replicate
autonomously, they may also replicate by being inserted into
the genome of the host cell, by methods well known in the
50 art.

(with and without integration within the genome) cultured
plant, mammalian or other eukaryotic cell lines. The puri
fication of nucleic acids produced by the methods of the
present invention are described, e.g., in Sambrook et al.,
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Expression and cloning vectors will likely contain a
Selectable marker, a gene encoding a protein necessary for
survival or growth of a host cell transformed with the vector.
The presence of this gene ensures growth of only those host
cells which express the inserts. Typical Selection genes

encode proteins that a) confer resistance to antibiotics or

1989 or Ausubel et al., 1992.

The polynucleotides of the present invention may also be
produced by chemical Synthesis, e.g., by the phosphoramid
ite method described by Beaucage and Caruthers, 1981, or
the triester method according to Matteucci and Caruthers,
1981, and may be performed on commercial, automated
oligonucleotide Synthesizers. A double-Stranded fragment
may be obtained from the Single-Stranded product of chemi
cal Synthesis either by Synthesizing the complementary
Strand and annealing the Strand together under appropriate
conditions or by adding the complementary Strand using
DNA polymerase with an appropriate primer Sequence.

Cold Spring Harbor, N.Y. (1983). See also, e.g., U.S. Pat.
Nos. 5,691,198; 5,735,500; 5,747,469 and 5,436,146.

other toxic Substances, e.g. amplicillin, neomycin,

methotrexate, etc., b) complement auxotrophic deficiencies,
or c) Supply critical nutrients not available from complex
60

media, e.g., the gene encoding D-alanine racemase for
Bacilli. The choice of the proper selectable marker will
depend on the host cell, and appropriate markers for differ

ent hosts are well known in the art.
65

The vectors containing the nucleic acids of interest can be
transcribed in vitro, and the resulting RNA introduced into

the host cell by well-known methods, e.g., by injection (see
Kubo, et al., 1988), or the vectors can be introduced directly
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into host cells by methods well known in the art, which vary
depending on the type of cellular host, including electropo
ration; transfection employing calcium chloride, rubidium
chloride calcium phosphate, DEAE-dextran, or other Sub
stances, microprojectile bombardment, lipofection; infec

Conventionally, in the wet milling process there is Separa
tion of the germ, hull gluten. In order to Separate Starch from
the corn kernel, for example, the kernels are Steeped in an
aqueous Solution under controlled conditions to Soften the
kernels and facilitate Separation of the kernels components.
After Steeping, the aqueous Solution is ground and Screened
So as to Separate the fibrous material and endosperm par
ticles from the Soluble protein, Starch and gluten. The Starch
and gluten are then Separated by their differences in density,
for example, by high-rate Washing centrifugation.
Alternatively, other methods may be employed in the iso
lation of Starch from Starch-containing plant tissue Such as
addition of cellulose at the milling Step or Separation of
Starch from oil-bearing Solids by centrifugation to promote
an oil-Solid phase Separation.
Enzyme Substrates included exogenous polysaccharides
of defined composition and plant extracts enriched for
endogenous polysaccharides. Direct conversion of plant
tissue into free Sugar was demonstrated by the production of
high cell density microbial cultures resulting from using
heated plant extracts as growth media.

tion (where the vector is an infectious agent, Such as a
retroviral genome); and other methods. See generally, Sam
brook et al., 1989 and Ausubel et al., 1992. The introduction

of the polynucleotides into the host cell by any method
known in the art, including, interalia, those described above,

will be referred to herein as “transformation.” The cells into
which have been introduced nucleic acids described above

are meant to also include the progeny of Such cells.
Large quantities of the nucleic acids and polypeptides of
the present invention may be prepared by expressing the
malA nucleic acid or portions thereof in Vectors or other
expression vehicles in compatible prokaryotic or eukaryotic
host cells. The most commonly used prokaryotic hosts are
Strains of Escherichia coli, although other prokaryotes, Such
as Bacillus Subtilis or Pseudomonas may also be used.
Mammalian or other eukaryotic host cells, Such as those
of yeast, filamentous fungi, plant, insect, or amphibian or
avian Species, may also be useful for production of the
proteins of the present invention. Propagation of mammalian
cells in culture is perse well known. See, Jakoby and Pastan
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EXAMPLES
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(eds.), 1979. Examples of commonly used mammalian host

cell lines are VERO and HeLa cells, Chinese hamster ovary

claims.

(CHO) cells, and WI38, BHK, and COS cell lines, although

it will be appreciated by the skilled practitioner that other
cell lines may be appropriate, e.g., to provide higher
expression, desirable glycosylation pattems, or other fea
tures. An example of a commonly used insect cell line is

Example 1

SF9.

Clones are Selected by using markers depending on the
mode of the vector construction. The marker may be on the
same or a different DNA molecule, preferably the same
DNA molecule. Production of a particular product based on
temperature Sensitivity may serve as an appropriate marker.
In prokaryotic hosts, the transformant may be Selected, e.g.,
by resistance to amplicillin, tetracycline or other antibiotics.
Prokaryotic or eukaryotic cells transformed with the poly
nucleotides of the present invention will be useful not only
for the production of the nucleic acids and polypeptides of
the present invention, but also, for example, in Studying the
characteristics of malA polypeptide.
The probes and primers based on the malA gene Sequence
disclosed herein are used to identify homologous malA gene
Sequences and proteins in other species. These gene
Sequences and proteins are used in the methods described
herein.

Method of Use: Bioprocessing of Plant Carbohydrates
Bioprocessing of plant carbohydrates Such as Starch cur
rently necessitates commodity enzyme additives to acceler
ate polysaccharide hydrolysis. Depolymerization is accom
plished by heat-based hydration followed by the addition of
microbial-derived thermostable hydrolases. To simplify the
current process, transgenic tobacco plants of the invention
were created which expressed hyperthermophilic glycosyl
hydrolase derived from the archaeon Sulfolobus Solfatari
cus. Hydrolysis, by recombinant glycosyl hydrolase, of
endogenous Starch present in Starch-containing plant tissues
Such as corn, wheat, milo and the like, was accomplished by
processing milled tissue, at high temperatures to activate the
recombinant protein. Alternatively, plant Starch was first
Separated from other components of the plant tissue and then
hydrolyzed by addition of recombinantly produced glycosyl
hydrolase and Subjecting the mixture to high temperatures.

The following examples are provided to further illustrate
the present invention and are not intended to limit the
invention beyond the limitations Set forth in the appended
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Cloning and Characterization of the Sulfolobus
Solfataricus malA Gene
Archaea constitute a third domain of organisms along
with eubacteria and eukaryotes. The Archaea was first
recognized in the early 1970s and includes Single-celled
organisms that are found in extreme environments Such as
Volcanic hot Springs and hypothermal vents in the deep
ocean. Members of the domain include the Methanogen,
Halophile and Sulfolobus genera. Members of the genus
Sulfolobus have been assigned to the crenarchaeotal Subdi
vision of the domain Archaea, of which Sulfolobus com

prises the largest genus. (Burggraf, et al., 1997). S. Solfa
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taricus is an aerobic, extremely thermophilic organism
found in acidic hot Springs. The ability of thermophiles,
including members of the Sulfolobus genus to grow on a
variety of Sugars and polysaccharides, is a result of their
Synthesis of alpha-glucosidases and beta-glycosidases. To
investigate poly-Saccharide utilization of maltose by Sul
folobus Species, the gene encoding the alpha-glucosidase
from S. Solfataricus was cloned and characterized.
Cloning of the gene was accomplished by using gene
specific PCR primers derived from the S. Solfataricus alpha
glucosidase protein Sequence Rolfsmeir et al., 1998. Amino
acid Sequencing indicated the mature N-terminal alpha
glucosidase sequence was MQTIKIYENLGVYLWIGEP

(SEQ.ID.NO:3). Since the purified S. Solfataricus alpha

glucosidase is generally resistant to proteolytic degradation

(Rolfsmeir and Blum, 1995) protein fragments for internal
60

N-terminal Sequence analysis were generated by chemical
cleavage with cyanogen bromide. A fragment of 19 kDa was
selected and yielded the N-terminal sequence VGKYL

LYAPI (SEQ.ID.NO:4). The resulting amino acid sequence

65

information was used to design degenerate oligonucleotides
which were then used to amplify a DNA fragment of 1.6 kb
by PCR. A 731-bp HindIII-EcoRV fragment derived from
the resulting 1.6-kb PCR product was used to generate a
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mobility shift analysis (Buratowski et al., In Ausubei, et al.,
1996) of the malA promoter region Suggests that sequences
3' to position about 70 (SEQ ID NO: 1) including a consen

radio labeled probe for Southern hybridization to verify the
origin of the amplification product. This probe croSS
hybridized with single DNA fragments of 1.2, 1.7, and 1.4
kb in HindIII, Xbal, and HincII genomic digests,
respectively, of S. Solfataricus DNA. The probe was used to
Screen a genomic S. SolfataricuS phage 2. library consisting
of 672 individually propagated recombinant phages by
Southern blot analysis. A Single isolate was identified

SuS archaeal TATA box, play an essential role in malA.
There is a potential archaeal promoter Sequence located

32 bp 5' to the start codon of the malA gene (FIG. 1B). The
putative promoter (TTTATA) closely matches the consensus
promoter sequence for Sulfolobus (Reiter, et al., 1988). A
box B motif (TGA) (Reiter, et al., 1988) is also evident 7 bp

(0.7F7), which contained a 15.1-kb insert of S. Solfataricus

DNA. Southern blot analysis of restriction digests of the
2.7F7 phage was performed with the PCR-derived probe.
Cross-hybridizing restriction fragments which were identi
cal in size to those observed previously with genomic DNA
were observed and indicated that the coding region for
alpha-glucosidase is contained in a 4.3-kb BamHI fragment
of the 27F7 insert. This 4.3-kb BamHI fragment was sub
cloned and Sequenced. The Sequence located immediately 5'
to the malA coding region was Subcloned from 27F7 as a
2.3-kb SacI-HindIII fragment. A 344-bp SacI-BamHI frag
ment from the extreme 5' end of this fragment was used as
a Southern blot probe to identify the next upstream over
lapping 2 clone from the genomic S. SolfataricuS 98/2
library. This isolate was named 2-1H4. A 4.1-kb HindIII
SacI fragment which cross-hybridized to the same SacI
BamHI344-bp fragment was subcloned from 2-1H4. A 2-kb
segment of this 4.1-kb HindIII-SacI fragment was
Sequenced to complete the analysis of putative genes lying
5' to malA. Analysis of regions lying 3' to the malA coding
region was done with a 1.8-kb 3' overlapping HindIII
HindIII fragment derived from 27F7. The resulting sequence
comprising a nearly 7-kb DNA contig. has been deposited in

5' to the malA start codon. Primer extension analysis indi
cated that malA transcription initiates on the guanine of the
putative box B motif. The mapped start site is 8bp 5' to the
malA Start codon. Although there is a potential ribosome

binding site spanning positions -3 to +3 (FIG. 2), which are
15

this sequence overlaps in part the Site of malA transcription
initiation. The utilization of this sequence for the initiation
of translation is therefore unclear. The malA mRNA is only
Slightly larger than the coding region of the gene. Since
transcription initiates very close to the Start of the coding
region, termination of transcription of the-gene must occur

close to the end of malA. The near-consensus terminator

sequence (TTTTTCA) (Daalgard, 1983) located immedi
25

gel shift analysis (Qureshi, 1995). Crude cell extracts pre
pared as described previously for use in an in vitro tran
scription system (Hudepohl, et al., 1990) were used as
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amino acid sequence (SEQ ID NO:2). The malA sequence

comprises 2,083 bp encoding a protein of 693 amino acids
with a predicted mass of 80.5 kDa. This closely corresponds
to the apparent mass of the previously purified natural

40

enzyme subunit (Rolfsmeier, et al., 1995). Sequence analy
sis of the deduced malA product identified a glycosyl
hydrolase motif at residues 316 to 323 and an ATP/GTP

binding site motif (P loop) at residues 583 to 590 (SEQ ID
NO: 2). The glycosyl hydrolase motif contains the putative
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active-site asparagine previously identified for the human

alpha-glucosidase gene (Hermans, et al., 1991). Only two

cysteine residues are evident, consistent with the low cyS
teine content Seen previously in thermophilic proteins. There
are 14 methionine residues, and the predicted mass of the
largest Sequence uninterrupted by methionines is 19 kDa as
Suggested by the-cyanogen bromide cleavage pattern of the
alpha-glucosidase. Examination of the 7.05 kb contig iden

tified several ORFs (FIG. 1A) with G+C contents of 37 to 38
mol %, as expected from previous analysis (DeRosa, et al.,
1975; Felsenstein, 1989). No sequence homologs of these
ORFS were evident in Searches of Sequence databases.
Within this contig, malA is flanked on the 5' side by an
unusual 1-kb intergenic region. It exhibits a G+C content of
30.8 mol %, a value considerably lower than that for the
flanking coding regions.
Northern blot analysis of the malA region identified
transcripts for malA and an upstream ORF located 5' to the
1-kb intergenic region. The malA transcription start Site was

located by primer extension analysis (Trienzenberg, 1992) to

a guanine residue 8 bp 5' of the malA Start codon. Gel

ately 3' to the Stop codon of malA may play a role in this

process (FIG. 2).

The interaction between purified archaeal TATA binding
proteins and archaeal promoters have been characterized by

Gen Bank (accession number AF042494, incorporated
herein by reference).
The alpha-glucosidase open reading frame (ORF) (malA)
of the present invention was identified by comparison of
peptide Sequences derived from the N-terminal and internal
N-terminal Sequencing of the natural protein to the deduced

complementary to the six 3'-terminal bases of the 16S rRNA

of S. Solfataricus (Kurosawa and Itoh, 1993; Zillig, 1993),

Sources of DNA binding proteins. The probe was a 233-bp
EcoRI fragment which starts 151 bp 5' to the malA tran
Scription start Site and extends 80 bp into the malA tran
Script. Addition of crude cell extract resulted in the forma
tion of two retarded protein DNA complexes. Both
complexes were eliminated by addition of the 233-bp EcoRI
malA promoter fragment as an unlabeled competitor DNA.
The more rapidly migrating complex (FIG. 4, complex B)
was lost in response to addition of competitor-DNA con
sisting of a 231-bp EcoRI-PvuII fragment from plasmid
pUC19, indicating that it was the result of nonspecific
interactions. Addition of a competitor DNA comprised of a
deletion derivative of the malA EcoRI promoter fragment,
lacking Sequences from bp -33 to +81, including the TATA
box (FIG. 1B, malA p-S), again eliminated only the lower
band. These results Suggest that Sequences located between
bp -33 and +81 (FIG. 2) are important features of the malA
promoter.

50

Amino acid Sequences of alpha-glucosidases and the
related Sucrase isomaltases were retrieved from the Swiss
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Prot and EMBL/Gen-Bank/DDBJ databases. A multiple
Sequence alignment of 6 bacterial and 11 eukaryotic
Sequences in addition to the S. Solfataricus Sequence was
made. The region of the S. SolfataricuS alpha-glucosidase
used for the alignment included 569 amino acid residues
spanning positions 50 to 618. The S. Solfataricus alpha
glucosidase is the only representative of the archaea, Since
no other archaeal alpha-glucosidases were found in the
databases. A conserved Stretch of amino acids located in the

middle of the three fungal Sequences was deleted to mini
mize Sequence gaps in the alignment. The alignment of
Sequences then was analyzed by distance, parSimony, and
maximum-likelihood methods. The E. coli malZ gene prod
uct was used as the outgroup. The Sequences clustered into
two groups typical of either eubacterial or eukaryotic
affiliation, under all three methods of analysis. Nearest
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neighbor distance analysis and parSimony analysis indicated
that the S. Solfataricus alpha-glucosidase is most closely
related to mammalian enzyme homologs. Maximum
likelihood analysis gave similar results.
Example 2
Distribution of the malA Gene Among Sulfolobus
Species
Southern blot analysis with a malA gene probe was
performed to analyze the distribution of this gene among the
three commonly cultivated Sulfolobus species. Two isolates
of S. Solfataricus were included in the analysis, strain 98/2
from Yellowstone National Park and strain P2 (DSM 1617)
from Italy. Genomic digests prepared with EcoRV (FIG.3A)
or HindIII (FIG. 3B) were then probed under stringent
hybridization conditions with a 731-bp EcoRV-HindIII
malA gene fragment encompassing nucleotides 714 to 1445
of the malA coding region (FIG. 2). Both strains of S.
Solfataricus exhibited strongly hybridizing bands of 2.9 kb
following EcoRV digestion and 1.2 kb following HindIII
digestion(FIG. 3, lanes 3 and 4), in agreement with the
Southern blot results obtained previously with the 731-bp
HindIII-EcoRV probe fragment derived from the initial
malA PCR product. For S. Shibatae, single weakly hybrid
izing bands of 0.65 kb following EcoRV digestion (FIG.3A,
lane 1) and 3.7 kb following HindIII digestion (FIG. 3B,
lane 1) were also observed. No cross-hybridization was
observed, however, between the S. Solfataricus malA gene
and S. acidocaldarius genomic DNA digests (FIGS. 3A and
B, lanes 2). Lack of a malA homolog or significant
C-glucosidase activity in S. acidocaldarius may be due to
the inability of S. acidocaldarius to utilize maltose as a Sole
carbon and energy source. (Rolfsmeier, et al. 1998). An
alpha-glucosidase thus may be essential for utilization of
maltose among certain members of the genus Sulfolobus.
This represents a distinguishing physiological feature for
Sulfolobus species identification.
Example 3
Isolation of DNA Encoding for Thermostable
Alpha-glucosidase from SulfolobuS SolfataricuS
Isolation of DNA encoding thermostable C-glucosidases
from hyperthermophilic members of Sulfolobus genus can
be accomplished using primers based on the glycosyl hydro
lase motif at residues 316 to 323 and the ATP/GTP binding
site motif (P loop) at residues 583 to 590 (single underline)
as shown in FIG. 2. The amino acid Sequence information
can be used to design degenerate oligonucleotides which can
be used to amplify DNA fragments by PCR. Restriction
fragments derived from the PCR products can be used to
generate a radio labeled probe for Screening genomic or
cDNA libraries of Sulfolobus species. Isolates can be iden
tified and restriction fragments can be analyzed for croSS
hybridization and Sub-cloning. Isolation of malA homologs
from other closely related archaea can be accomplished by
Screening recombinant DNA libraries of the target organism
with probes derived from the malA gene. To obtain
homologs from more distantly related archaea antibodies
can be raised against malA as probes to Screen expression
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Rolfsmeier, et al., 1995.
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The purified, recombinant enzyme hydrolyzes p-nitro
phenyl-O-D-glucopyranoside with a Km of 2.16 mM and a
V of 3.08 umol of p-nitrophenol/min at 85 C. It exhib

ited a pH optimum for maltose hydrolysis of 4.5 (FIG. 4A).
50

In contrast to its apparent greater tendency to dissociate
during SDS-PAGE, the recombinant alpha-glucosidase
exhibits greater thermoStability than the natural enzyme with
a half-life of 39 hat 85°C. at a pH of 6.0. The half-life for

the natural enzyme is 11 h at 85°C. (Rolfsmeier et al., 1995).
55
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Alpha-glucosidases of mammalian origin are generally
distinguished from those of higher plants and eubacteria by
their affinities for glycogen as a Substrate. Surprisingly,
glycogen is hydrolyzed efficiently by alpha-glucosidase
from S. Solfataricus. The recombinant alpha-glucosidase

exhibits a pH optimum for glycogen hydrolysis of 5.5 (FIG.
4B), a Km of 64.9 mg/ml, and a V of 1.0 umol of
glucose/min at 85 C.
Recombinant enzyme purification of beta-glycosidase

Characterization

malA gene encoding of hyperthermophilic alpha
glucosidase, was confirmed by expression in E. coli. The
recombinant enzyme was then purified and characterized.

Increasing expression is accomplished by changing
codons which are not heavily used in the host species,
whether microbial or plant. Codon usage tables are available
for many plant hosts, including tobacco, thus the identifi
cation of which codons to change and what to change them
to as well as the method to do it are well known in the art.

libraries.

Example 4
Expression of Recombinant Alpha-glucosidase
Activity in Escherichia coli and its Purification and

22
A 2.1-kb region spanning bp 141 to 2265 (FIG. 2),
encompassing the malA coding region and 30 bp of flanking
Sequence, was blunted and cloned into the SmaI site of
pUC19. This construct was then digested with Kpn1 and
Pst1, and the resulting 2.1-kb fragment was Subcloned into
the Kpn1 and Pst1 sites of plasmid pLITMUS 29 (New
England Biolabs). The pITIMUS 29 derivative was then
digested with Stu1 and PvulI and religated to itself to
remove a T7 promoter located 3' to the malA sequence. The
resulting plasmid was introduced into E. coli DH5C. for
production of the recombinant protein by using Stationary
phase cell Suspensions, typically in 0.5 liter amounts.
Purification of the recombinant enzyme to apparent
homogeneity employed heat fractionation of clarified cell
Sonicates followed by anion-exchange fast protein liquid
chromatography and gel filtration fast protein liquid chro
matography as described by Rolfsmeier, et al., 1995. The
recombinant S. Solfataricus alpha-glucosidase exhibited Sig
nificant recalcitrance to denaturation as indicated by its
behavior during denaturing SDS-PAGE. Despite boiling in
the presence of 2% (wt/vol) SDS for 10 minutes, the
alpha-glucosidase failed to enter the Separating gel and
instead migrated in Significant amounts (representing 45%
of the total observed protein) in the Stacking gel. However,
95% of the natural enzyme treated in an identical manner
was in the multimeric form (Rolfsmeier, et al., 1995),
Suggesting that the recombinant enzyme dissociates more
readily under these conditions. Complete denaturation of the
recombinant alpha-glucosidase required additional treat
ment with 6 M guanidine hydrochloride, resulting in exclu
sive formation of the 80-kDa monomer. Assays for alpha
glucosidase activity with p-nitrophenyl-C-Dglucopyranoside were performed as described by
Rolfsmeier, et al., 1995. In enzymatic assays for hydrolysis
of maltose and glycogen, release of glucose was monitored
with a glucose oxidase assay kit (Sigma) as described by
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was performed using transformants of E. coli DH5C. (Gibco
BRL) harboring the lacS expression plasmid pBN55. The
Strain was grown at 37 C. with vigorous shaking in 4 liters
of LB medium containing amplicillin (100 tug/ml) until the
cells reached Stationary phase. Cells were harvested by
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After transformation and regeneration of tobacco leaf
disks with Vector containing the malA or lacS gene, 17
rooted tobacco regenerants were identified by their positive
reaction on NPT II ELISA as having been transformed with
the T-DNA from Agrobacterium tumefaciens containing the

23
centrifugation, resuspended in 30 mM morpholinepropane

sulfonic acid, pH 8.0 (MOPS buffer) and lysed by Sonication
at 4 C. The resulting lysates were clarified by centrifugation
(3,000xg for 30 min.) and then heated at 85°C. for 30 min.
and reclarified by centrifugation. The heating and centrifu
gation procedure was then repeated a Second time. The
heat-treated Supernatants were concentrated by ultrafiltra

gene.
Based on the methods described herein and the data

tion using a YM3 (Amicon) membrane.

presented, those of skill in the art would be able to construct
plants expressing both glycosyl hydrolases.

The concentrated Supernatants were applied to a Mono Q

FPLC (fast protein liquid chromatography) column
(Parmacia) previously equilibrated with MOPS buffer. The

Example 6

recombinant B-glycosidase was eluted with linear gradients

Preparation of Enzyme Concentrate from Tobacco

of Sodium chloride in MOPS buffer. Active fractions of the

Extract

enzyme were identified by enzyme assay, pooled, concen

trated by ultrafiltration using a PM10 (Amicon) membrane,
and dialyzed into 100 mM sodium phosphate buffer (pH
6.0). The dialyzed samples were applied to a Superdex 200
HR 10/30 FPLC column (Pharmacia) previously equili
brated with 100 mM sodium phosphate (pH 6.0). Active
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were harvested, rinsed with distilled water, midribs removed

fractions were again pooled and concentrated by ultrafiltra
tion.

Example 5
Transformation of Tobacco Plants by
Agrobacterium tumefaciens Transformed with a
Binary Plasmid Containing the malA or lacS Genes
During the cloning of the malA gene into the plant vector,
candidate colonies were Screened by growing overnight in
LB broth containing the appropriate antibiotic, pelleting the
cells and resuspending them in 0.1 M Sodium acetate at pH
4.5. ASSay for alpha-glucosidase was performed with para
nitrophenyl-C-D-glucopyranoside as described in
Rolfsmeier, et al., 1995. In order to construct the binary
plasmid, the malA gene which had been cloned from a
genomic library of Sulfolobus Solfataricus strain 98/2
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Sequence and about 30 bp of 5" flanking Sequence, was first

cloned into the vector pGEM 7Zf+ (Promega) to pick up
enhanced 35S promoter (5) and the 35S polyadenylation site
(3) of the pRTL2 plasmid which was provided by J. C.
Carrington, after the TEV leader Sequence (Carrington and
Freed, 1990; Carrington, et al., 1990) had been removed by

40

45

50

promoter within the T-DNA near the left border, resulting in
a plasmid in which the gene of interest inserts first into the
55

described in Haseltine, et al., 1999(a). A pPZP112 derivative

expressing lacS was constructed using the same Strategy as

described for malA.

The resulting binary vector plasmid constructs were used
to transform Agrobacterium tumefaciens strain C58C1 by
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the freeze-thaw method (An et al., 1988). The bacteria was
then used to transform tobacco (Nicotiana tabacum cv.
Xanthi) by the leaf disk method (Horsch et al., 1985).
instructions.

Example 7
Detection of Recombinant Alpha-glucosidase and
Beta-glycosidase Activity in Nicotiana tabacum and
Determination of its Substrate Specificity
ASSays of recombinant alpha-glucosidase from concen
trated tobacco extract used by alpha-linked para

nitrophenlglucoside (Sigma) or 4-methylumbelliferyl-C-Dglucoside (4-MUG) (Sigma) as Substrates at concentrations

Rooted regenerants were identified as transformants by

detection of NPT II in leaf tissue with the ELISA kit (5
Prime 3 Prime, Inc.), according to the manufacturer's

plant which was harvested and ground to a fine powder in
liquid nitrogen. The ground leaves were resuspended in 2
volumes of 100 mM sodium phosphate pH 7.0 with 10 mM
beta-mercaptoethanol and the tissue was further homog
enized in a Waring blender. The resulting extracts were then
incubated at 80 C. to activate the recombinant alpha
glucosidase and beta-glycosidase for 48 hours. After
incubation, the extracts were clarified by centrifugation by
12,500 rpm for 10 minutes 4 C. Glucose released by
glycosyl hydrolase action on endogenous plant carbohy
drates was measured using the Glucose Oxidase ASSay

(Sigma).

genome (Hajdukiewicz, et al., 1994). The lacS gene includ

ing its bacterial expression System and antibodies were as

tissue extracts for Studies on hydrolysis of added defined
Substrates were prepared using 100 g of tobacco leaves were
harvested and grinded to a fine powder in liquid nitrogen.
The leaf powder was resuspended in 500 ml of 10 mM
tris-Cl pH7.0 to which 10 mM beta-mercaptoethanol has
been added. The Suspension was then homogenized in a
Waring blender. The resulting extract was centrifuged at
5,000 rpm for 30 minutes at 4 C. and the Supernatant was
further clarified by filtering through three layers of cheese
cloth. Plant extracts used for Studies on hydrolysis of endog
enous polysaccharides as Sources of transgenic proteins

were prepared using one leaf (medium to large) for each

digestion with XhoI and Bam HI. The resulting expression
cassette was Subcloned into the multiple cloning site of the

binary vector pPZP112 (Hajdukiewicz, et al., 1994)at the Pst
I site (near right T-DNA border) to produce the construct
pPB709, shown in FIG.1. The pPZP112 vector contains the
neomycin phosphotransferase (NPT II) gene under the 35S

and weighed. Leaves were then ground to a powder in liquid
nitrogen and ground again with a sterilized pestle. The
extracts were then clarified by centrifugation at 14,000 rpm
for 10 minutes at room temperature. The resulting Superna
tant was heat treated for 1 hour at 85 C. and clarified by
Spinning at 14,000 rpm for 10 minutes at room temperature.
The Supernatant was collected and assayed for alpha
glucosidase or beta-glycosidase enzyme activity by measur
ing the hydrolysis of p-nitrophenyl-alpha-glucopyranoside

(alpha-PNPG) and p-nitrophenyl-beta-D-glucopyranoside
(beta-PNPG), respectively, as previously described
(Rolfsmeier, et al., 1998; Haseltine, et al., 1999(a)). Plant

(pBN56; Rolfsmeier et al., 1998), containing the coding

useful restriction sites. The malA open reading frame and 30
bp lying both 5' and 3' was then cloned between the

To obtain tobacco leaf extract for assays, approximately

100 g of tobacco (five 1.1 cm diameter disk punches) leaves
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of 1 mM in 0.05M sodium acetate buffer at pH 4.5. Total
protein was quantified using the Bradford protein assay kit

from BioRad (Bradford, 1976). Extract was incubated one
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hour at 85 C. and re-clarified to remove any endogenous
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radation of this material is apparent and resulted from
proteolysis during preparation of the E. coli extract. No
croSS-reacting material was evident in whole cells extracts

tobacco alpha-glucosidase. Extract and Substrate were pre

warmed for 10 minutes then combined in a reaction volume

of 300 ul, layered with 150 ul mineral oil and incubated 3
hours at 85 C. Aliquots of 25 ul were removed after Zero
and three hours of incubation and transferred to Stop Solution
consisting of 1 M Na2CO. The reaction product,
4-methylumbelliferone, was detected on a DyNAQuant 200
fluorometer. Each extract was assayed in duplicate. Routine
assays of beta-glycosidase were performed as described by
Haseltine, et al., 1999(a).
Tobacco leaf extracts to be used for detection of glycosyl
hydrolase antigens were concentrated 3-fold by (NH). SO
precipitation. Westem blot analysis followed protocols from
Sambrook, et al., 1989. Preparations were made 1x in
SDS-PAGE sample buffer and 30 ug total protein per well
was oaded on a 12% SDS polyacrylamide gel (8% stacking)
and electrophoresed ccording to Haseltine, et al., 1999(b).
Proteins (Amersham) were transferred to nitrocellulose and
incubated. Chemiluminescent (colormetric) western blots
were performed as described by Rolfsmeier, et al., 1998. The
recombinant E coli extracts used as controls for the alpha
glucosidase and the beta-glycosidase on Western blots were
prepared as previously described (Haseltine, et al., 1999(b)).
Concentrated plant protein extracts were diluted 1:10 in 10
mM tris-Cl pH 7.0.50 ul of anti-malA antibodies were added

from E. coli lacking the lacS expression plasmid (lane 3).
Similar results were obtained for plants transformed with the
malA gene expression construct (FIG. 12A). Recombinant
alpha-glucosidase protein produced using a recombinant E.
coli expression Strain (Sunna, 1997) was used as a positive
control (FIG. 12A, lane 1). A protein with an apparent mass

of 80 kDa and identical to the positive control sample mass
was detected in extracts of the T2 plant MI52E but not in
extracts of the plant transformed with the empty vector

(lanes 2 and 3, respectively).
Precipitation of tobacco leaf proteins with (NH). SO

15

heat inactivation (1 hr., 55° C). Background due to endog

25

to 200 ul of diluted extract and incubated for 2 hours at 4

C. with gentle agitation. After incubation, an equivalent of
350 lug of protein A was added and the mixture was
incubated for 3 hours at 4 C. and the Supernatant was
collected and assayed for alpha-glucosidase activity using
the MUG assay. Blots were soaked with a chemiluminescent

Substrate Solution (Amersham) and results visualized by

autoradiography and quantified by densitometry.
The substrate 4-MUG broke down at 85°C., pH 4.5, to
form fluorescent product at about the same rate in the
presence or absence of tobacco leaf extract made from plants
transformed with the empty vector pPZP112. When 1 mM
4-MUG was incubated with extract from a plant transformed
with the malA gene, the rate of product formation was close
to Six times the rate of product formation in the presence of
extract made from empty vector control. Fluorescence due to
endogenous compounds in tobacco extracts was unchanged
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tative isolates of twenty-two independent events exhibited
enzyme specificity over a 13-fold range with maximum

55
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these results, the very high background appears to have been
due to one or more endogenous tobacco enzymes active at
room temperature, and acting on added Starch during the
interval between combining the reaction components and
transferring reaction mixes from 250 to 85 C. The back
ground in the absence of added Starch might have been due
to nonenzymatic degradation of an endogenous glucose
polymer, or due to formation of compounds that interfere
with the glucose oxidase assay.
AS with the empty vector extract, the background in the
absence of Starch was lower than the background in the
presence of added Starch, rising from 1.3 to 5.3 micrograms
of glucose per 100 microliters in 16 hours, and was not

affected by pre-treatment of one hour at 85°C. (FIG. 7). The

umoles PNP/min/mg of protein (FIG. 5B). Eight represen

values of 13 pmoles PNP/hr/mg protein (FIG. 5A).
The protein identity of the thermostable glycosyl hydro
lase activities was confirmed by Western blot analysis of
60

background in the presence of added Starch was greatly
reduced by the one-hour pre-treatment, but was dependent
on incubation time at 85 C., and was still substantially
greater than the background in the absence of added Starch,
rising from 2.0 to 10.2 micrograms of glucose per 100
microliters in 16 hours. The net rate of glucose formation,
which is believed to represent the conversion of added starch
to glucose by the recombinant alpha-glucosidase, was 0.42

micrograms per hour (FIG. 7).

extracts derived from the T2 plant JJ-6, transformed with the
lacS gene, detected a protein with an apparent mass of 60

kDa (FIG. 12B, lane 1). No cross-reacting material was
evident in extracts from a plant transformed with an empty

was used as a positive control for these experiments. Deg

pre-heated before assay, the background in the absence of
Starch was unchanged, but the background in the presence of
Starch was then at the same level as the background in the

absence of starch without pre-heating (FIG. 7). Based on

Glucosyl hydrolase levels were determined in primary
plant transformants using clarified leaf extracts incubated at
80 C. Plants transformed with empty vector lacked detect
able thermostable glycosyl hydrolase activity. Activity was
measured on fully expanded leaves of plants that had grown
in soil for 76 to 164 days. Levels of the beta-glycosidase in
young primary transformants was determined in twenty
three independent events. Enzyme levels in ten representa
tive isolates ranged over 12-fold with maximum values of 29

vector (lane 2). Recombinant beta-glycosidase produced
using a recombinant E. coli expression Strain (Sunna, 1997)

enous glucose was removed by dialysis. Initial attempts to
assay concentrated extract from tobacco transformed with
malA vector or empty vector, with or without 5% starch as
Substrate, failed to demonstrate activity in the malA tobacco
extract due to a very high background in the presence of the
Starch. In an attempt to remove this background, concen
trated empty vector control eXtract was pre-incubated for
one hour at 85°C., clarified by microcentrifugation and then
incubated for 0 or 14 hour at 85 C. in the presence or
absence of 5% starch. Without preincubation, background in
the presence of Starch was very high, at both 0 and at 14
hours, corresponding to 17.8 to 19.2 micrograms of glucose
per 100 microliters of assay. Background in the absence of
Starch was much lower, but apparently more time
dependent, rising from 0.9 to 1.6 micrograms of glucose per

100 microliters in 14 hours (FIG. 7). When the extract was

35

for four hours at 85 C.

plant extracts (FIG. 12). Western blot analysis of plant

achieved a 3-fold concentration of the recombinant alpha
glucosidase with a recovery of 100%. Endogenous plant
glycolytic activities were eliminated prior to malA assays by
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Since significantly greater amounts of plant extract were
required to detect the alpha-glucosidase compared to the
beta-glycosidase, additional experiments using protein
immunoprecipitation were conducted to further confirm

alpha-glucosidase production (FIG. 12C). A sample of T2

plant MI52E extract was treated with the anti-alpha
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glucosidase antibody and antibody-antigen complexes were
removed by StaphylococcuS protein-A treatment. The
residual activity remaining in the treated Samples was then
determined by enzyme assay. Additional Samples of T2 plant
MI52E extract treated with Staphylococcus protein A alone
or with no treatment were also analyzed for residual alpha
glucosidase activity. Nearly complete removal of alpha
glucosidase was evident in Samples treated with the anti
alpha-glucosidase antibodies but not in untreated Samples or
in samples treated only with protein A. The results verify
production of the thermostable glycosyl hydrolases in

Analysis of enzyme levels in fully expanded leaf tissue
Samples from identical T2 plants collected over time indi
cated that the glycosyl hydrolase activities increased as the

plants matured (FIG. 11). Total protein was measured on
5

(Sunna, 1997), levels of the alpha-glucosidase were low in

younger plants and reached appreciable levels as plants aged

and following flower formation (FIG. 11B). Total protein
levels in contrast were most elevated in younger plants and
decreased significantly as the plants aged. A similar novel
pattern of accumulation was observed for transgenic plants

tobacco leaves.

For measurements of glycosyl hydrolase activities on
glucose polymers. An equal volume of -20° C. acetone was
added to extract, followed by storage at -20°C. for one hour
and centrifugation for 30 minutes at 10,000xg (GSA rotor,
rp.m.). Pellets were lyophilized, then resuspended with
about 1/100 the original volume of 10 mM tris HCl pH 7 and
clarified by microcentrifugation. After incubating one hour
at 85 C. and reclarifying, extracts were lyophilized to
remove free glucose and Small Solutes that could interfere
with the glucose oxidase assay. ASSays of alpha-glucosidase
on starch used soluble potato starch (from Fluka) at 5%
(w/v) in 0.05 M Sodium acetate buffer, pH 4.5. Aliquots of
100 ul were removed at four hour intervals and glucose was
detected with a glucose oxidase glucose detection kit from
Sigma.
The recombinant alpha-glucosidase from tobacco was
active on maltose and a number of other O-(1->4) linked
glucose polymers, as shown in Table 1. This demonstrates
that the recombinant hydrolases of the present invention are
useful for release of other Sugars in addition to glucose.

both a fresh weight and leaf area basis. In contrast to the
expected pattern observed with most transgenic proteins

producing the beta-glycosidase (FIG. 11A).
Example 9

15

Stability of Recombinant Glycosyl Hydrolases in
Preserved Plant Tissue

It has been determined that glycosyl hydrolaseS retain
Significant activity in fully mature and preserved leaf tissue.
Glycosyl hydrolase Specific activities in plant tissues were
compared, after freezing or drying, to levels in fresh tissue

25

Samples (Table 2). Significant beta-glycosidase activity was
retained in leaves harvested and held at -80 C. for 5 days.
In contrast, the alpha-glucosidase activity was over two

times more stable when frozen and 17 times more stable

when dried, as compared to fresh tissues.
The retention of transgenic glycosyl hydrolase activities
in preserved plant tissues confirms that the plant tissue can
be stored for later use as a Source of hydrolase activity. This
means that crops traditionally used for forage would be
useful and appropriate hosts Since they are left in the field
until after winter.

TABLE 1.

Substrate Specificity of the
Sulfolobus solfataricus C. glucosidase

35

TABLE 2

Stability of Recombinant Glycosyl Hydrolases

Specific Activity (umoles
Substrate
Maltose
Maltotriose
Maltotetrose

3.32 - 0.46
1.17 O.26
1.91 - 0.61

Maltoheptose
Sucrose

148
1.29

Dextrin (1% w/v)

0.85 + 0.04

Starch (1% w/v)
Starch (5% w/v)

4.75 - O.S
8.67 + O.O

Glycogen (1% w/v)
Glycogen (5% w/v)

in Preserved Plant Tissue

glucose/min/mg)
40

Frozen
Dried
Fresh

OOO
O.O3

30 minutes at 80 C.

50
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67
31
62

3.6
27
1.6

Autodigestion of Plant Substrates by Thermostable
Enzymes
Conversion of plant polysaccharide into free Sugar is
conventionally done by addition of purified or Semipurified
hydrolytic enzymes. AS an example of the use of endog
enous thermostable enzymes for plant bioprocessing, the
ability of plant protein extracts to hydrolyze polysaccharides

such as starch was demonstrated (FIGS. 7A and 7B). Protein

Tobacco Plants

T2 were obtained by Screening Seed for kanamycin resis
tant germination. Single copy transgene insertions were
identified as yielding kanamycin resistance Segregation fre
quencies of 3:1 in T3 Seed. T2 plants harboring Single
insertions from Several independent lines were used for
detailed experiments. Of the 17 NPT II-positive tobacco
plants, nine had Sufficient levels of the alpha-glucosidase to
be detected with reasonable certainty. Recovery of tobacco
plants producing the beta-glycosidase occurred at frequen
cies Similar to those of the alpha-glucosidase.

Alpha-glucosidase
(umoles PNP/hr/mg)

Example 10

Indicates the assay was performed with the recombinant enzyme.

Example 8
Expression and Accumulation of Recombinant
Glycosyl Hydrolases by Second Generation

Beta-glycosidase
(umoles PNP/min/mg)

45

O.52 O.O7
3.75 O.3

Substrate concentrations were 10 mM except dextrin, starch and glycogen
which were performed at the concentrations listed. Assays were performed

Condition

60

extracts of the alpha-glucosidase transgenic plant MI52E,
were prepared and combined with soluble starch. Plant
leaves were harvested in the late afternoon, ground in liquid
nitrogen with a mortar and pestle in 100 mM phosphate
buffer at pH 7.0. Upon incubation at 80 C., glucose was
released in a manner which was collinear with time. No
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Significant glucose was detected in reactions containing
protein extracts from plants transformed with empty vector
and added Starch or in reactions containing Starch alone. The
rate of appearance of glucose was 0.11 lug/hr for alpha
glucosidase and 0.15 lug/hr for beta-glucosidase. These
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SEQUENCE LISTING

<160> NUMBER OF SEQ ID NOS: 4
<210> SEQ ID NO 1
&2 11s LENGTH 228O
&212> TYPE DNA

<213> ORGANISM: Sulfolobus solfataricus
&22O > FEATURE

<221 NAME/KEY: CDS
<222> LOCATION: (172). . (2250)
<400

SEQUENCE: 1

taggaattat cqaattcaac gotttitccaa taaatactaa ttggitttaaa cittaacgtta

60

tgtagittagt tattgtcata atcc.gaaaaa aggataacaa totagttgtt taggataaac

120

tagataaagg aagctittata ttittgaagag aattgtatac ggtgataag g g at g cag

177

Met Glin
1

aca ata aaa at a tac gag aac aaa goc gtt tac aaa gta gtt ata gga

225

Thir Ile Lys Ile Tyr Glu Asn Lys Gly Val Tyr Lys Val Val Ile Gly
5

10

15

gaa cca titt coc coc at a gaa titc cca citt gag caa aag ata toa tog

273

Glu Pro Phe Pro Pro Ile Glu Phe Pro Leu Glu Gln Lys Ile Ser Ser
2O

25

30

aat aaa tot tta to a gag ttg ggit tta aca at a gtt caa caa got aac

321

Asn Lys Ser Lieu Ser Glu Lieu Gly Lieu. Thir Ile Val Glin Glin Gly Asn
35

40

45

5O

aag gtt att gtc gag aaa to a ttg gat ttg aaa gag cac attata gga

369

Lys Val Ile Val Glu Lys Ser Lieu. Asp Lieu Lys Glu His Ile Ile Gly
55

60

65

ttg gga gag aag gC g titt gag titg gat aga aag agg aaa agg tat gtg

417

Leu Gly Glu Lys Ala Phe Glu Lieu. Asp Arg Lys Arg Lys Arg Tyr Val
70

75

8O

atg tat aac gtt gac got ggg gct tat aag aaa tat caa gat coa citt

465

Met Tyr Asn Val Asp Ala Gly Ala Tyr Lys Lys Tyr Glin Asp Pro Leu
85

90

95

tac gtt agt at a coc tta titt ata to a gtg aaa gac ggc gtt gca act

513

Tyr Val Ser Ile Pro Leu Phe Ile Ser Val Lys Asp Gly Val Ala Thr
1 OO

105

110

ggit tac titc titc aac to a gCt tot aaa gtg atc titc gac gtg gga citt

5 61

Gly Tyr Phe Phe Asin Ser Ala Ser Lys Val Ile Phe Asp Val Gly Leu
115

120

125

130

gag gaa tac gat aaa gta att gtt aca att coa gag gac to a gta gag

609

Glu Glu Tyr Asp Llys Val Ile Val Thr Ile Pro Glu Asp Ser Val Glu
135

14 O

145

ttt tac gtg att gala ggg cca aga att gag gac gtt ct a gag aaa tac

657

Phe Tyr Val Ile Glu Gly Pro Arg Ile Glu Asp Val Leu Glu Lys Tyr
15 O

155

160

acg gag citt acc gga aaa cct titc cita cct coc at g togg gct titc ggit

Thr Glu Leu Thr Gly Lys Pro Phe Leu Pro Pro Met Trp Ala Phe Gly
1.65

170

175

705
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36
-continued

tac

atg ata toa cgc tac tct tac tac cc c cag
Met Ile Ser Arg
Ser
Pro Glin

gat aag gtt gtt gag
Asp Lys Wall Wall Glu

18O

190

tta gta
Teu Wall

185

gat ata atg Cala aag gag ggit titt aga gta gct gga gta titc.
Asp Ile Met Glin Lys Glu Gly Phe Arg Wall Ala Gly Wall Phe

195
tta
Teu

200

2O5

gat ata cac tac atg gac
Asp Ile His Tyr Met Asp
cca

Arg Phe
aac

gtt aag
Lys

849

aag cita att gac gaa tta cac aag aga
Telu Ile Asp Glu Teu His Lys Arg
235
24 O

897

a Ca alta gtt gac cac gga alta agg gtt gat cag
Ile Thr Ile Wall Asp His Gly Ile Arg Wall Asp Glin
25 O
255

945

220

gaa cct
Glu Pro

a.a.a.

Lel

cca

260

agt ggit gaa
Ser

Gly

Glu

Lys

cca

titt citt to c gga

Phe Teu Ser
265

Gly

gta ggit

a.a.a.

cita titc.
Lel

275

Pro

225

cita att

245
aat tat toa
Asn Tyr Ser

tgg cat
Trp His

cct
Pro

230

Asn Wall

Phe Wall
280

Gly

atg gga
Met

a.a.a.

titc.

Gly Lys

Phe
270

atg tgg
Trp

Met

cct
Pro

gag att gaa
Glu Ile Glu

993

gtc

O 41

ggit

act act

Gly

Thr Thr Wall Tyr
290

285

gac titc.
agg gag gat act aga gaa tgg tgg gct ggg
Asp Phe Phe Arg Glu Asp Thr Arg Glu Trp Trp Ala Gly
295

to c gaa
Ser Glu

tgg
Trp

3OO

citt toa Cala gga gtt
Lel Ser Glin Gly Wall

310

tat

tta atc
Telu Ile

gat ggit
tgg
Asp Gly Ile Trp

cita gac atg aat
Teu Asp Met Asn

315

act gac titc. tct agg

325
tta cc c gta cag titc. aga
Ser Telu Pro Wall Glin Phe Arg

34 O

gat
Asp

gta gtt

cac

tac

Asn Wall Wall His

Tyr

a.a. C.

355

gat gat aga
Asp Asp Arg

citt gtt acc act titt cca
Teu Wall Thr Thr Phe Pro

345

350

Teu

agg gga aag agg gtt
Arg Gly Lys Arg Wall

360

gaa a.a.a.
His Glu Lys

a.a.a. cac

365

375

Phe Arg

38O

cct toa
Pro Ser

395

ggit

400
425

tgg gat gat
Trp Asp Asp

473

att tot
Ser Ile Ser

ggit gta

Gly

435

act

Cala cita Cala
gtt citc. ggC tta
Telu Glin Telu Glin Teu Wall Teu Gly Telu

4.25

430

cca

titt

gta ggit

gat

alta

ggit gga

titt

Gly Cys Asp

Ile

Gly Gly

Phe Glin
450

gat
Asp

tta tta gtc
Teu Teu Wall

4 45

a.a. C. titc. gCg gaa att gac a.a. C. tot atg
Asn Phe Ala Glu Ile Asp Asn Ser Met

460

Cala

a.a.a.

ata

569

465

gat acg gaa cca gtt titc. citg cca gat tac tat aag
Ile Asp Thr Glu Pro Wall Phe Teu Pro Asp Tyr Tyr Lys
485
490
495

Gly

521

Lys

gct tta gcc ttg titc. titc. cc c titc. tat agg toa cac aag gca
Ala Telu Ala Teu Phe Phe Pro Phe
Arg Ser His Lys Ala
470
475
480

gat ggit

Thr Asp

Lys

aag citt
Teu

Wall Pro Phe Wall
4 40

455
tat tat

377

Gly

Cala aga tac gca titc. atc
act ggit gat aat acc
Ile Glin Arg
Ala Phe Ile Trp Thr Gly Asp Asn Thr
405
410
415

tog

ggC agg

329

Gly

420

Gly Arg

281

385

agc cat agg aat gaa ata titt atc
agt aga gcc
Thr Ser His Arg Asn Glu Ile Phe Ile Teu Ser Arg Ala

tat gcc gga ata

Ala

233

370

aCa

390

185

335

gtt aga aat gct tat cct tta tat gag gct atg gca acg titt aag ggg
Wall Arg Asn Ala Tyr Pro Teu
Glu Ala Met Ala Thr Phe Lys Gly
titt agg

137

320

att gag atc aga gac

330

tog

O89

305
att

gaa
gct
gtt tta tot
Glu Pro Thr Asp Phe Ser Arg Ala Ile Glu Ile Arg Asp Wall Leu Ser
cca

801

210

to c tat aag tta titt a Ca
Ser
Lys Teu Phe Thr

215
tat agg titc.

75.3

617

665
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38
-continued

gag aaa gta aag gaa atc gtg gag titg agg tat aag titc tta coc tat

713

Glu Lys Wall Lys Glu Ile Val Glu Lieu Arg Tyr Lys Phe Leu Pro Tyr
5 OO

505

510

att tat to c tta gct tta gag got agt gag aag gga cat cog gta att

761

Ile Tyr Ser Lieu Ala Leu Glu Ala Ser Glu Lys Gly His Pro Val Ile
515

52O

525

530

aga cot cita ttt tac gaa titc cag gat gat gac gac atg tat aga ata

809

Arg Pro Leu Phe Tyr Glu Phe Glin Asp Asp Asp Asp Met Tyr Arg Ile
535

540

545

gala gac gag tat atg gtt got aag tat ttg citt tac got coa att gta

857

Glu Asp Glu Tyr Met Val Gly Lys Tyr Leu Leu Tyr Ala Pro Ile Val
550

555

560

agt aaa gag gag agt agg tta gta aca tta cott aga. g.gt aag togg tac

905

Ser Lys Glu Glu Ser Arg Lieu Val Thr Lieu Pro Arg Gly Lys Trp Tyr
565

570

575

aat tac tog aat ggc gag ata ata aac ggit aag agt gtt gtt aag tot

95.3

Asn Tyr Trp Asn Gly Glu Ile Ile Asn Gly Lys Ser Val Val Lys Ser
58O

585

590

act cat gag ttg cca att tac titg aga. gala gga toa ata atc cc g ttg

2001

Thr His Glu Leu Pro Ile Tyr Leu Arg Glu Gly Ser Ile Ile Pro Leu
595

600

605

610

gag ggit gac gag tta ata gtt tac ggit gag acc tog titc aag cqt tac

2O49

Glu Gly Asp Glu Lieu. Ile Val Tyr Gly Glu Thir Ser Phe Lys Arg Tyr
615

62O

625

gat aat gct gala att acc toc to a agt aat gala att aag titt to a agg

2097

Asp Asn Ala Glu Ile Thr Ser Ser Ser Asn. Glu Ile Lys Phe Ser Arg
630

635

640

gag att tat gta tot aag cita act atc aca toa gag aaa cca gtg agc
Glu Ile Tyr Val Ser Lys Leu Thir Ile Thr Ser Glu Lys Pro Val Ser
645

650

2145

655

aag ata at a gtt gac gat agt aag gala att caa gta gag aag aca atg

21.93

Lys Ile Ile Val Asp Asp Ser Lys Glu Ile Glin Val Glu Lys Thr Met
660

665

670

caa aac act tac gtt gct aag att aat caa aaa att agg gga aag att

2241

Glin Asn. Thir Tyr Val Ala Lys Ile Asn Gln Lys Ile Arg Gly Lys Ile
675

680

685

690

aac cta gag tagttttittc acgtacticca agg acttaac

228O

Asn Lieu. Glu

<210> SEQ ID NO 2
&2 11s LENGTH 693
&212> TYPE PRT

<213> ORGANISM: Sulfolobus solfataricus

<400

SEQUENCE: 2

Met Glin Thr Ile Lys Ile Tyr Glu Asn Lys Gly Val Tyr Lys Val Val
1

5

10

15

Ile Gly Glu Pro Phe Pro Pro Ile Glu Phe Pro Leu Glu Gln Lys Ile
2O

25

30

Ser Ser Asn Lys Ser Leu Ser Glu Lieu Gly Lieu. Thir Ile Val Glin Glin
35

40

45

Gly Asn Lys Val Ile Val Glu Lys Ser Lieu. Asp Leu Lys Glu His Ile
5O

55

60

Ile Gly Lieu Gly Glu Lys Ala Phe Glu Lieu. Asp Arg Lys Arg Lys Arg
65

70

75

8O

Tyr Val Met Tyr Asn. Wall Asp Ala Gly Ala Tyr Lys Lys Tyr Glin Asp
85

90

95

Pro Leu Tyr Val Ser Ile Pro Leu Phe Ile Ser Val Lys Asp Gly Val
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40
-continued

100

Ala Thr

Gly

Wall Ile Phe
125

Asp Lys Wall Ile Wall Thr Ile

Telu Glu

130

135

Wall Glu Phe
145

Phe

110

Phe Phe Asn Ser Ala Ser
120

115

Gly

105

Wall Ile Glu
15 O

Thr Glu Teu Thr
1.65

Gly

Met Ile Ser

Arg

Gly

Pro Glu

Wall

Asp

Ser

140

Gly

Pro

Arg Ile Glu Asp Wall

Telu Glu

155

160

Pro Phe Teu Pro Pro Met

170

Trp Ala
175

Pro Glin

Ser

185

Asp Lys Wall
190

Wall Glu Telu Wall Asp Ile Met Glin
195
200

Glu

Phe Arg Wall Ala

Gly

Wall Phe Telu Asp Ile His Tyr Met
210
215

Ser

Lys

Trp

Arg Phe

His Pro
225

Arg

Asn Wall

Lys

Pro Glu Pro

Teu Ile

230

235

Lel

245

Asp Glin

Asn

Tyr

Ile Glu Ser
275

Gly

Glu

Lel

Phe Wall
280

Gly

Gly

Asp Glu

Telu His

240

Ile Thr Ile Wall Asp His
250
Phe Telu Ser
265

Ser

260

Teu Phe Thr

220

Met

Gly

Met

Trp

Gly

Ile Arg Wall
255
Phe
27 O

Cys Glu
Thr Thr

Pro

285

Wall Tyr Pro Asp Phe Phe Arg Glu Asp Thr Arg Glu Trp Trp Ala
29 O
295
Teu Ile Ser Glu

Trp

305

Lel

Ser Glin

Gly

310

Met Asn Glu Pro Thr

Asp Phe

Ser

Wall Asp
315

Gly

Ile Trp Telu Asp
320

Arg Ala Ile Glu Ile Arg Asp Wall

325

330

Teu Ser Ser Telu Pro Wall Glin Phe

340

Gly

335

Arg Asp Asp Arg

Teu Wall Thr Thr

345

350

Phe Pro Asp Asn Wall Wall His Tyr Telu Arg
355
360

Gly

Glu Lys Wall Arg Asn Ala Tyr Pro Telu
370
375

Glu Ala Met Ala Thr Phe
38O

Lys Gly Phe Arg Thr

Ser His

385

390

Ala

Gly

Ala

Gly

Arg

Asn Glu Ile Phe Ile Teu Ser

395

Trp Asp Asp

Telu

420

Gly

435

Phe Glin
450

Gly Arg

Lys

Telu Glin Teu Glin Teu Wall Telu

430

Wall Pro Phe Wall
4 40

Asn Phe Ala Glu Ile

Asp

Gly

Asp Ile Gly Gly
4 45

Asn Ser Met

Gly
485

Glu Lys Wall
5 OO
Ile
515

Asp

Telu Telu

Arg

Ser His

460

Ala Teu Ala Telu Phe Phe Pro Phe
470
475
Thr Asp

Pro

Gly

455

Wall
465

400

425

Telu Ser Ile Ser

Arg

Ala Phe Ile Trp Thr Gly Asp
410
415

Ile Glin Arg

405
Asn Thr Pro Ser

Arg Wall Lys His
365

480

Ile Asp Thr Glu Pro Wall Phe Teu Pro Asp Tyr
490
495
Glu Ile Wall Glu Teu Arg
505

Ser Teu Ala Telu Glu Ala Ser Glu

52O

Tys Phe

Telu

510

Lys
525

His Pro
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-continued

Wall Ile
530

Arg Pro Leu Phe Tyr Glu Phe Glin Asp Asp Asp Asp Met
535

540

Arg Ile Glu Asp Glu Tyr Met Wall Gly Lys Tyr Teu Teu Tyr Ala Pro
545

550

Ile Wall Ser

555

560

Gly Lys

Glu Glu Ser Arg Lieu Wall Thir Leu Pro
565
570

575

Trp Tyr Asn Tyr Trp Asn Gly Glu Ile Ile Asn Gly Lys Ser Wal Wall
585

59 O

Ser Thr His Glu Leu Pro Ile Tyr Telu Arg Glu Gly
595

Pro

Telu Glu

600

Gly Asp Glu Teu Ile Wall

610

Arg
625

Ser Ile Ile

605

Gly Glu Thr

Ser Phe

615

Tyr Asp Asn Ala Glu Ile Thr Ser Ser Ser Asn. Glu Ile
630

Glu Ile Tyr Wall Ser
645

Ser

Telu Thr Ile Thir Ser Glu Lys
650
655

Wall Ser Lys Ile Ile Wall Asp Asp Ser
660
665
Thr Met Glin
675

Asn Thr

Phe
640

635

Wall Ala
680

Pro

Glu Ile Glin Wall Glu
670

Lys Ile Asn Gln Lys Ile Arg Gly
685

Ile Asn Lieu. Glu
69 O.

SEQ ID NO 3
LENGTH 19
TYPE PRT

ORGANISM: Sulfolobus solfataricus
<400 SEQUENCE: 3

Met Glin Thr Ile Lys Ile Tyr Glu Asn Leu Gly Val Tyr Leu Trp Ile
1

5

10

15

Gly Glu Pro
SEQ ID NO 4
LENGTH
TYPE

10
PRT

ORGANISM: Sulfolobus solfataricus

<400

SEQUENCE: 4

Val Gly Lys Tyr Lieu Lleu Tyr Ala Pro Ile
1

5

10

I claim:

1. A method for converting plant Substrate, comprising
heating Said Substrate in the presence of recombinant hyper
thermophilic glycosyl hydrolase, wherein Said Substrate
comprises extract of plant transformed with Said recombi
nant hyperthermophilic glycosyl hydrolase, and wherein the
glycosyl hydrolase is localized with the Substrate in tissue of
the plant.
2. The method of claim 1, wherein said plant substrate
further comprises a plant extract enriched for Said Substrate

55

60

COntent.

3. The method of claim 1, wherein said hyperthermophilic
glycosyl hydrolase is from Sulfolobus species.
4. The method of claim3 wherein said Sulfolobus species
is Selected from the group consisting of S. SolfataricuS 98/2,
S. Shibatae, S. acidocaldarius, and S. Solfataricus P2.

5. The method of claim 1, wherein said hyperthermophilic
glycosyl hydrolase is Selected from the group consisting of
hyperthermophilic alpha-glucosidase, hyperthermophilic
beta-glycosidase and combinations thereof.
6. The method of claim 5, wherein said hyperthermophilic
glycosyl hydrolase is hyperthermophilic alpha-glucosidase.
7. The method of claim 5, wherein said hyperthermophilic
glycosyl hydrolase is hyperthermophilic beta-glycosidase.
8. The method of claim 1 wherein said plant substrate
comprises polysaccharide.
9. The method of claim 1, wherein said Substrate is heated

at a temperature of between about 65 C. and about 85 C.
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